ES2553753T3 - Compuestos de quinuclidina como ligandos del receptor nicotínico de acetilcolina alfa7 - Google Patents

Info

Publication number

ES2553753T3

ES2553753T3 ES09733949.3T ES09733949T ES2553753T3 ES 2553753 T3 ES2553753 T3 ES 2553753T3 ES 09733949 T ES09733949 T ES 09733949T ES 2553753 T3 ES2553753 T3 ES 2553753T3

Authority

ES

Spain

Prior art keywords

mmol

pyrimidinyl

methyl

amine

octan

Prior art date

2008-04-23

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Active

Links

• Espacenet
• Global Dossier
• Discuss

• OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 title description 7
• 229960004373 acetylcholine Drugs 0.000 title description 7
• 239000003446 ligand Substances 0.000 title description 6
• 150000008584 quinuclidines Chemical class 0.000 title description 2
• 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 1050
• -1 quinaxolinilo Chemical group 0.000 claims abstract description 459
• 150000001875 compounds Chemical class 0.000 claims abstract description 84
• 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims abstract description 40
• 125000004076 pyridyl group Chemical group 0.000 claims abstract description 39
• 150000003839 salts Chemical class 0.000 claims abstract description 31
• 125000000714 pyrimidinyl group Chemical group 0.000 claims abstract description 29
• 125000001424 substituent group Chemical group 0.000 claims abstract description 25
• 229910052757 nitrogen Inorganic materials 0.000 claims abstract description 24
• 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract description 23
• 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims abstract description 21
• 125000004765 (C1-C4) haloalkyl group Chemical group 0.000 claims abstract description 18
• 125000000229 (C1-C4)alkoxy group Chemical group 0.000 claims abstract description 17
• 125000004767 (C1-C4) haloalkoxy group Chemical group 0.000 claims abstract description 16
• 125000001425 triazolyl group Chemical group 0.000 claims abstract description 12
• 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 claims abstract description 11
• 125000000335 thiazolyl group Chemical group 0.000 claims abstract description 11
• 125000004093 cyano group Chemical group *C#N 0.000 claims abstract description 10
• 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 10
• 125000003373 pyrazinyl group Chemical group 0.000 claims abstract description 10
• 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 claims abstract description 9
• 125000001624 naphthyl group Chemical group 0.000 claims abstract description 9
• 125000002294 quinazolinyl group Chemical group N1=C(N=CC2=CC=CC=C12)* 0.000 claims abstract description 9
• 125000001544 thienyl group Chemical group 0.000 claims abstract description 9
• 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 claims abstract description 8
• 125000000000 cycloalkoxy group Chemical group 0.000 claims abstract description 8
• 239000001257 hydrogen Substances 0.000 claims abstract description 8
• 125000003453 indazolyl group Chemical group N1N=C(C2=C1C=CC=C2)* 0.000 claims abstract description 8
• 125000002098 pyridazinyl group Chemical group 0.000 claims abstract description 8
• 125000002853 C1-C4 hydroxyalkyl group Chemical group 0.000 claims abstract description 6
• 125000004103 aminoalkyl group Chemical group 0.000 claims abstract description 6
• 125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 claims abstract description 6
• 125000004612 furopyridinyl group Chemical group O1C(=CC2=C1C=CC=N2)* 0.000 claims abstract description 6
• 125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 claims abstract description 6
• 125000004593 naphthyridinyl group Chemical group N1=C(C=CC2=CC=CN=C12)* 0.000 claims abstract description 6
• 125000004193 piperazinyl group Chemical group 0.000 claims abstract description 6
• 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 claims abstract description 6
• 125000001567 quinoxalinyl group Chemical group N1=C(C=NC2=CC=CC=C12)* 0.000 claims abstract description 6
• JBOYQZDFEWOILV-UHFFFAOYSA-N 5h-chromene Chemical compound O1C=CC=C2CC=CC=C21 JBOYQZDFEWOILV-UHFFFAOYSA-N 0.000 claims abstract description 5
• 125000004433 nitrogen atom Chemical group N* 0.000 claims abstract description 4
• 125000002393 azetidinyl group Chemical group 0.000 claims abstract description 3
• 125000004604 benzisothiazolyl group Chemical group S1N=C(C2=C1C=CC=C2)* 0.000 claims abstract description 3
• 125000004603 benzisoxazolyl group Chemical group O1N=C(C2=C1C=CC=C2)* 0.000 claims abstract description 3
• 125000002883 imidazolyl group Chemical group 0.000 claims abstract description 3
• 125000001041 indolyl group Chemical group 0.000 claims abstract description 3
• 125000000842 isoxazolyl group Chemical group 0.000 claims abstract description 3
• 125000002757 morpholinyl group Chemical group 0.000 claims abstract description 3
• 125000001715 oxadiazolyl group Chemical group 0.000 claims abstract description 3
• 125000002971 oxazolyl group Chemical group 0.000 claims abstract description 3
• 125000003386 piperidinyl group Chemical group 0.000 claims abstract description 3
• 125000003226 pyrazolyl group Chemical group 0.000 claims abstract description 3
• 125000000719 pyrrolidinyl group Chemical group 0.000 claims abstract description 3
• 125000001113 thiadiazolyl group Chemical group 0.000 claims abstract description 3
• 125000004306 triazinyl group Chemical group 0.000 claims abstract description 3
• 125000004414 alkyl thio group Chemical group 0.000 claims abstract 4
• 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract 4
• 125000005843 halogen group Chemical group 0.000 claims description 17
• 238000011282 treatment Methods 0.000 claims description 11
• 208000024827 Alzheimer disease Diseases 0.000 claims description 10
• WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 9
• GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 9
• 229910052794 bromium Inorganic materials 0.000 claims description 9
• 201000000980 schizophrenia Diseases 0.000 claims description 9
• 125000000217 alkyl group Chemical group 0.000 claims description 8
• 125000003545 alkoxy group Chemical group 0.000 claims description 3
• 125000003354 benzotriazolyl group Chemical group N1N=NC2=C1C=CC=C2* 0.000 claims description 3
• 125000006402 chloropyridazinyl group Chemical group 0.000 claims description 3
• 239000003937 drug carrier Substances 0.000 claims description 3
• 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 3
• 125000006393 methylpyrimidinyl group Chemical group 0.000 claims description 3
• 239000008194 pharmaceutical composition Substances 0.000 claims description 3
• 229910052799 carbon Inorganic materials 0.000 claims description 2
• 125000006390 chloropyrimidinyl group Chemical group 0.000 claims description 2
• 125000004769 (C1-C4) alkylsulfonyl group Chemical group 0.000 claims 4
• 125000006396 chloropyrazinyl group Chemical group 0.000 claims 2
• 125000001309 chloro group Chemical group Cl* 0.000 claims 1
• 150000003852 triazoles Chemical class 0.000 claims 1
• 125000001475 halogen functional group Chemical group 0.000 abstract 2
• XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 370
• IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 331
• 238000005481 NMR spectroscopy Methods 0.000 description 323
• OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 303
• ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 281
• 238000006243 chemical reaction Methods 0.000 description 207
• 239000000203 mixture Substances 0.000 description 202
• HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 149
• VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical class CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 142
• HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 141
• 235000019439 ethyl acetate Nutrition 0.000 description 128
• WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 123
• YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 121
• HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 120
• 239000007787 solid Substances 0.000 description 108
• 239000000843 powder Substances 0.000 description 94
• 239000000047 product Substances 0.000 description 91
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 90
• 238000005160 1H NMR spectroscopy Methods 0.000 description 76
• VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 76
• 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 71
• 239000000741 silica gel Substances 0.000 description 70
• 229910002027 silica gel Inorganic materials 0.000 description 70
• 238000004587 chromatography analysis Methods 0.000 description 67
• 238000000034 method Methods 0.000 description 66
• 239000000243 solution Substances 0.000 description 64
• CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 60
• 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 55
• 239000011541 reaction mixture Substances 0.000 description 54
• VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 52
• 235000011114 ammonium hydroxide Nutrition 0.000 description 51
• CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 50
• OKKJLVBELUTLKV-VMNATFBRSA-N methanol-d1 Chemical compound [2H]OC OKKJLVBELUTLKV-VMNATFBRSA-N 0.000 description 48
• ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 44
• BDNKZNFMNDZQMI-UHFFFAOYSA-N 1,3-diisopropylcarbodiimide Chemical compound CC(C)N=C=NC(C)C BDNKZNFMNDZQMI-UHFFFAOYSA-N 0.000 description 43
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 41
• RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 39
• IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 37
• VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 36
• FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 36
• QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 34
• 239000012043 crude product Substances 0.000 description 33
• QGJOPFRUJISHPQ-UHFFFAOYSA-N Carbon disulfide Chemical compound S=C=S QGJOPFRUJISHPQ-UHFFFAOYSA-N 0.000 description 32
• 239000000908 ammonium hydroxide Substances 0.000 description 32
• 239000002244 precipitate Substances 0.000 description 31
• PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 30
• WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 30
• DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 30
• 229910052938 sodium sulfate Inorganic materials 0.000 description 30
• 235000011152 sodium sulphate Nutrition 0.000 description 30
• 239000008346 aqueous phase Substances 0.000 description 29
• 238000004440 column chromatography Methods 0.000 description 29
• 238000003818 flash chromatography Methods 0.000 description 28
• CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 27
• IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 26
• 229910000085 borane Inorganic materials 0.000 description 25
• 239000012267 brine Substances 0.000 description 25
• 229910000024 caesium carbonate Inorganic materials 0.000 description 25
• 229910052943 magnesium sulfate Inorganic materials 0.000 description 25
• 235000019341 magnesium sulphate Nutrition 0.000 description 25
• HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 25
• YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 24
• 239000012074 organic phase Substances 0.000 description 24
• 239000000725 suspension Substances 0.000 description 23
• 125000004202 aminomethyl group Chemical group [H]N([H])C([H])([H])* 0.000 description 22
• OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 22
• 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 21
• 239000003921 oil Substances 0.000 description 21
• 235000019198 oils Nutrition 0.000 description 21
• KXMMNJQMGILZDB-UHFFFAOYSA-N 1-(2-oxopyridine-1-carbothioyl)pyridin-2-one Chemical compound O=C1C=CC=CN1C(=S)N1C(=O)C=CC=C1 KXMMNJQMGILZDB-UHFFFAOYSA-N 0.000 description 20
• CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 20
• 235000011089 carbon dioxide Nutrition 0.000 description 20
• 239000013058 crude material Substances 0.000 description 20
• RAFNCPHFRHZCPS-UHFFFAOYSA-N di(imidazol-1-yl)methanethione Chemical compound C1=CN=CN1C(=S)N1C=CN=C1 RAFNCPHFRHZCPS-UHFFFAOYSA-N 0.000 description 20
• 239000012071 phase Substances 0.000 description 20
• HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 19
• OUKVGTYIZUXBIR-JZGIKJSDSA-N [(3s)-3-hydroxy-1-azoniabicyclo[2.2.2]octan-3-yl]methylazanium;dichloride Chemical compound Cl.Cl.C1CC2[C@@](CN)(O)CN1CC2 OUKVGTYIZUXBIR-JZGIKJSDSA-N 0.000 description 19
• 238000000746 purification Methods 0.000 description 19
• 238000004809 thin layer chromatography Methods 0.000 description 19
• UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 17
• HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 17
• TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 16
• 239000002904 solvent Substances 0.000 description 16
• XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 15
• 238000001914 filtration Methods 0.000 description 15
• 238000003756 stirring Methods 0.000 description 15
• 238000012360 testing method Methods 0.000 description 15
• 210000004027 cell Anatomy 0.000 description 14
• INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 14
• OKJPEAGHQZHRQV-UHFFFAOYSA-N Triiodomethane Natural products IC(I)I OKJPEAGHQZHRQV-UHFFFAOYSA-N 0.000 description 13
• 230000003287 optical effect Effects 0.000 description 13
• 229910000029 sodium carbonate Inorganic materials 0.000 description 13
• 235000017550 sodium carbonate Nutrition 0.000 description 13
• YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 13
• UONKGCZCROZZCD-QMMMGPOBSA-N (3s)-3-(aminomethyl)-1-azabicyclo[2.2.2]octan-3-ol Chemical compound C1CC2[C@@](CN)(O)CN1CC2 UONKGCZCROZZCD-QMMMGPOBSA-N 0.000 description 12
• 102000019315 Nicotinic acetylcholine receptors Human genes 0.000 description 12
• 108050006807 Nicotinic acetylcholine receptors Proteins 0.000 description 12
• 239000000706 filtrate Substances 0.000 description 12
• NSPMIYGKQJPBQR-UHFFFAOYSA-N 4H-1,2,4-triazole Chemical compound C=1N=CNN=1 NSPMIYGKQJPBQR-UHFFFAOYSA-N 0.000 description 11
• DUKKRSPKJMHASP-UHFFFAOYSA-N 6-chloropyrimidin-4-amine Chemical compound NC1=CC(Cl)=NC=N1 DUKKRSPKJMHASP-UHFFFAOYSA-N 0.000 description 11
• KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 11
• 150000001412 amines Chemical class 0.000 description 11
• XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 10
• 238000003556 assay Methods 0.000 description 10
• CAACGBPGDBJKFK-UHFFFAOYSA-N azanium;ethyl acetate;hydroxide Chemical compound [NH4+].[OH-].CCOC(C)=O CAACGBPGDBJKFK-UHFFFAOYSA-N 0.000 description 10
• UORVGPXVDQYIDP-UHFFFAOYSA-N borane Chemical compound B UORVGPXVDQYIDP-UHFFFAOYSA-N 0.000 description 10
• 238000012512 characterization method Methods 0.000 description 10
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
• 230000014759 maintenance of location Effects 0.000 description 10
• 239000000463 material Substances 0.000 description 10
• 102000005962 receptors Human genes 0.000 description 9
• 108020003175 receptors Proteins 0.000 description 9
• 108091006146 Channels Proteins 0.000 description 8
• DTQVDTLACAAQTR-UHFFFAOYSA-M Trifluoroacetate Chemical compound [O-]C(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-M 0.000 description 8
• 239000003795 chemical substances by application Substances 0.000 description 8
• 150000002500 ions Chemical class 0.000 description 8
• 235000017557 sodium bicarbonate Nutrition 0.000 description 8
• 229910000030 sodium bicarbonate Inorganic materials 0.000 description 8
• VPRKGLYZWQCCHU-UHFFFAOYSA-N 6-pyridin-3-ylpyrimidin-4-amine Chemical compound C1=NC(N)=CC(C=2C=NC=CC=2)=N1 VPRKGLYZWQCCHU-UHFFFAOYSA-N 0.000 description 7
• 201000010099 disease Diseases 0.000 description 7
• 239000000543 intermediate Substances 0.000 description 7
• 208000015122 neurodegenerative disease Diseases 0.000 description 7
• 229920006395 saturated elastomer Polymers 0.000 description 7
• 239000007858 starting material Substances 0.000 description 7
• 208000019022 Mood disease Diseases 0.000 description 6
• JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 6
• PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 6
• RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 6
• WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 6
• 239000004202 carbamide Substances 0.000 description 6
• 239000003153 chemical reaction reagent Substances 0.000 description 6
• 239000003814 drug Substances 0.000 description 6
• RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Chemical group C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 6
• 239000007788 liquid Substances 0.000 description 6
• ZNNZYHKDIALBAK-UHFFFAOYSA-M potassium thiocyanate Chemical compound [K+].[S-]C#N ZNNZYHKDIALBAK-UHFFFAOYSA-M 0.000 description 6
• 238000010992 reflux Methods 0.000 description 6
• 208000024891 symptom Diseases 0.000 description 6
• UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 description 6
• KRRTXVSBTPCDOS-UHFFFAOYSA-N 5-bromopyrazin-2-amine Chemical compound NC1=CN=C(Br)C=N1 KRRTXVSBTPCDOS-UHFFFAOYSA-N 0.000 description 5
• BLGYAIWJMVWVDS-UHFFFAOYSA-N 6-methoxy-[1,2,4]triazolo[1,5-a]pyridin-2-amine Chemical compound C1=C(OC)C=CC2=NC(N)=NN21 BLGYAIWJMVWVDS-UHFFFAOYSA-N 0.000 description 5
• KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 5
• 125000003368 amide group Chemical group 0.000 description 5
• 230000003920 cognitive function Effects 0.000 description 5
• 230000000694 effects Effects 0.000 description 5
• 150000002540 isothiocyanates Chemical class 0.000 description 5
• QJPQVXSHYBGQGM-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 QJPQVXSHYBGQGM-UHFFFAOYSA-N 0.000 description 5
• 230000002441 reversible effect Effects 0.000 description 5
• 238000010898 silica gel chromatography Methods 0.000 description 5
• 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 5
• OHUNPVCHRGBDHH-AWEZNQCLSA-N (3r)-n-(6-methoxypyrimidin-4-yl)spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound C1=NC(OC)=CC(NC=2O[C@@]3(C4CCN(CC4)C3)CN=2)=N1 OHUNPVCHRGBDHH-AWEZNQCLSA-N 0.000 description 4
• PXWGDZJDUOPMGQ-IBGZPJMESA-N (3r)-n-(6-phenylpyridazin-3-yl)spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound C([C@]1(C2CCN(CC2)C1)O1)N=C1NC(N=N1)=CC=C1C1=CC=CC=C1 PXWGDZJDUOPMGQ-IBGZPJMESA-N 0.000 description 4
• OEBYXCLQXOTPJE-SFHVURJKSA-N (3r)-n-(6-pyridin-4-ylpyrimidin-4-yl)spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound C([C@]1(C2CCN(CC2)C1)O1)N=C1NC(N=CN=1)=CC=1C1=CC=NC=C1 OEBYXCLQXOTPJE-SFHVURJKSA-N 0.000 description 4
• RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 4
• VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 4
• NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 4
• WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 description 4
• 102000004310 Ion Channels Human genes 0.000 description 4
• 108090000862 Ion Channels Proteins 0.000 description 4
• LSDPWZHWYPCBBB-UHFFFAOYSA-N Methanethiol Chemical compound SC LSDPWZHWYPCBBB-UHFFFAOYSA-N 0.000 description 4
• 235000019502 Orange oil Nutrition 0.000 description 4
• 241000700159 Rattus Species 0.000 description 4
• 239000000556 agonist Substances 0.000 description 4
• 230000027455 binding Effects 0.000 description 4
• YNHIGQDRGKUECZ-UHFFFAOYSA-L bis(triphenylphosphine)palladium(ii) dichloride Chemical compound [Cl-].[Cl-].[Pd+2].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 YNHIGQDRGKUECZ-UHFFFAOYSA-L 0.000 description 4
• 229940045348 brown mixture Drugs 0.000 description 4
• 239000000872 buffer Substances 0.000 description 4
• 229940079593 drug Drugs 0.000 description 4
• MXDFPKDNQYNZPK-UHFFFAOYSA-N ethyl n-(5-chloro-[1,3]thiazolo[5,4-d]pyrimidin-2-yl)carbamate Chemical compound N1=C(Cl)N=C2SC(NC(=O)OCC)=NC2=C1 MXDFPKDNQYNZPK-UHFFFAOYSA-N 0.000 description 4
• 239000010502 orange oil Substances 0.000 description 4
• XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 4
• 229940116357 potassium thiocyanate Drugs 0.000 description 4
• 230000000750 progressive effect Effects 0.000 description 4
• HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 description 4
• 238000004007 reversed phase HPLC Methods 0.000 description 4
• 239000011734 sodium Substances 0.000 description 4
• 125000000446 sulfanediyl group Chemical group *S* 0.000 description 4
• 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 4
• RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 4
• 239000003981 vehicle Substances 0.000 description 4
• SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 3
• QOWBXWFYRXSBAS-UHFFFAOYSA-N (2,4-dimethoxyphenyl)methanamine Chemical compound COC1=CC=C(CN)C(OC)=C1 QOWBXWFYRXSBAS-UHFFFAOYSA-N 0.000 description 3
• QJJUSLVVKXQFHE-AWEZNQCLSA-N (3r)-n-(3,5-dichloropyridin-2-yl)spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound ClC1=CC(Cl)=CN=C1NC(O1)=NC[C@]11C(CC2)CCN2C1 QJJUSLVVKXQFHE-AWEZNQCLSA-N 0.000 description 3
• ZPJGZIRGDFKHDQ-LBPRGKRZSA-N (3r)-n-(3-methyl-1,2,4-oxadiazol-5-yl)spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound CC1=NOC(NC=2O[C@@]3(C4CCN(CC4)C3)CN=2)=N1 ZPJGZIRGDFKHDQ-LBPRGKRZSA-N 0.000 description 3
• UHFZBJIRVAMIPP-LBPRGKRZSA-N (3r)-n-(3-methyl-1,2,4-thiadiazol-5-yl)spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound CC1=NSC(NC=2O[C@@]3(C4CCN(CC4)C3)CN=2)=N1 UHFZBJIRVAMIPP-LBPRGKRZSA-N 0.000 description 3
• FKMFBGHZRUFUCP-HNNXBMFYSA-N (3r)-n-(4,5-dimethylpyrimidin-2-yl)spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound N1=C(C)C(C)=CN=C1NC(O1)=NC[C@]11C(CC2)CCN2C1 FKMFBGHZRUFUCP-HNNXBMFYSA-N 0.000 description 3
• KHQUNFNAMOIACW-AWEZNQCLSA-N (3r)-n-(5,6-dichloropyridin-2-yl)spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound N1=C(Cl)C(Cl)=CC=C1NC(O1)=NC[C@]11C(CC2)CCN2C1 KHQUNFNAMOIACW-AWEZNQCLSA-N 0.000 description 3
• WGPOVCLCAWPGGU-INIZCTEOSA-N (3r)-n-(5-bromo-4-propan-2-ylpyrimidin-2-yl)spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound C1=C(Br)C(C(C)C)=NC(NC=2O[C@@]3(C4CCN(CC4)C3)CN=2)=N1 WGPOVCLCAWPGGU-INIZCTEOSA-N 0.000 description 3
• NLSADPPBWBUTDK-HNNXBMFYSA-N (3r)-n-(5-chloro-[1,3]thiazolo[5,4-b]pyridin-2-yl)spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound C1N(CC2)CCC2[C@]1(O1)CN=C1NC1=NC2=CC=C(Cl)N=C2S1 NLSADPPBWBUTDK-HNNXBMFYSA-N 0.000 description 3
• JORBPZWZVPZZKU-SFHVURJKSA-N (3r)-n-(5-cyclopentyloxypyrimidin-2-yl)spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound C1CCCC1OC(C=N1)=CN=C1NC(O1)=NC[C@]11C(CC2)CCN2C1 JORBPZWZVPZZKU-SFHVURJKSA-N 0.000 description 3
• QBDRIJRFLYTRHO-ZDUSSCGKSA-N (3r)-n-(5-ethyl-1,3,4-oxadiazol-2-yl)spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound O1C(CC)=NN=C1NC(O1)=NC[C@]11C(CC2)CCN2C1 QBDRIJRFLYTRHO-ZDUSSCGKSA-N 0.000 description 3
• LLSDHTXRWBJQEM-LBPRGKRZSA-N (3r)-n-(5-methyl-1,3,4-oxadiazol-2-yl)spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound O1C(C)=NN=C1NC(O1)=NC[C@]11C(CC2)CCN2C1 LLSDHTXRWBJQEM-LBPRGKRZSA-N 0.000 description 3
• HWESYGNLBMIHIM-AWEZNQCLSA-N (3r)-n-(5-methylsulfanylpyrazin-2-yl)spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound C1=NC(SC)=CN=C1NC(O1)=NC[C@]11C(CC2)CCN2C1 HWESYGNLBMIHIM-AWEZNQCLSA-N 0.000 description 3
• RHHQETAYCGOKDB-QFIPXVFZSA-N (3r)-n-(5-phenylmethoxy-[1,3]thiazolo[5,4-b]pyridin-2-yl)spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound C=1C=C2N=C(NC=3O[C@@]4(C5CCN(CC5)C4)CN=3)SC2=NC=1OCC1=CC=CC=C1 RHHQETAYCGOKDB-QFIPXVFZSA-N 0.000 description 3
• FTBWMNKCUZZEKB-FQEVSTJZSA-N (3r)-n-(5-phenylpyridin-3-yl)spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound C([C@]1(C2CCN(CC2)C1)O1)N=C1NC(C=1)=CN=CC=1C1=CC=CC=C1 FTBWMNKCUZZEKB-FQEVSTJZSA-N 0.000 description 3
• HNEWBIIZRVBLEW-KRWDZBQOSA-N (3r)-n-(5-pyrrolidin-1-ylpyrazin-2-yl)spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound C1CCCN1C(N=C1)=CN=C1NC(O1)=NC[C@]11C(CC2)CCN2C1 HNEWBIIZRVBLEW-KRWDZBQOSA-N 0.000 description 3
• JEIHYUJKPUPKOT-AWEZNQCLSA-N (3r)-n-(6-bromo-[1,3]thiazolo[4,5-b]pyrazin-2-yl)spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound C1N(CC2)CCC2[C@]1(O1)CN=C1NC1=NC2=NC=C(Br)N=C2S1 JEIHYUJKPUPKOT-AWEZNQCLSA-N 0.000 description 3
• SPSBIAARVKFBRI-ZDUSSCGKSA-N (3r)-n-(6-bromopyridazin-3-yl)spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound N1=NC(Br)=CC=C1NC(O1)=NC[C@]11C(CC2)CCN2C1 SPSBIAARVKFBRI-ZDUSSCGKSA-N 0.000 description 3
• LENPKGRPSYLBFA-ZDUSSCGKSA-N (3r)-n-(6-chloropyridazin-3-yl)spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound N1=NC(Cl)=CC=C1NC(O1)=NC[C@]11C(CC2)CCN2C1 LENPKGRPSYLBFA-ZDUSSCGKSA-N 0.000 description 3
• MMPRRMIZZMKFAF-SFHVURJKSA-N (3r)-n-(6-cyclopentyloxypyrimidin-4-yl)spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound C1CCCC1OC1=CC(NC=2O[C@@]3(C4CCN(CC4)C3)CN=2)=NC=N1 MMPRRMIZZMKFAF-SFHVURJKSA-N 0.000 description 3
• PYHHMEHCCLGBHQ-INIZCTEOSA-N (3r)-n-(6-fluoro-1h-indazol-3-yl)spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound C1N(CC2)CCC2[C@]1(O1)CN=C1NC1=NNC2=CC(F)=CC=C21 PYHHMEHCCLGBHQ-INIZCTEOSA-N 0.000 description 3
• CZLTXTIEEPGFOS-SFHVURJKSA-N (3r)-n-(6-methoxyquinoxalin-2-yl)spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound C1N(CC2)CCC2[C@]1(O1)CN=C1NC1=NC2=CC=C(OC)C=C2N=C1 CZLTXTIEEPGFOS-SFHVURJKSA-N 0.000 description 3
• WTSNUTQIWJIIGD-SFHVURJKSA-N (3r)-n-(6-methylquinoxalin-2-yl)spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound C1N(CC2)CCC2[C@]1(O1)CN=C1NC1=NC2=CC=C(C)C=C2N=C1 WTSNUTQIWJIIGD-SFHVURJKSA-N 0.000 description 3
• AMXYESZREAWKMZ-AWEZNQCLSA-N (3r)-n-(6-methylsulfanylpyrimidin-4-yl)spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound C1=NC(SC)=CC(NC=2O[C@@]3(C4CCN(CC4)C3)CN=2)=N1 AMXYESZREAWKMZ-AWEZNQCLSA-N 0.000 description 3
• NTZKNOCUCKBRFH-IBGZPJMESA-N (3r)-n-(6-phenoxypyrimidin-4-yl)spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound C([C@]1(C2CCN(CC2)C1)O1)N=C1NC(N=CN=1)=CC=1OC1=CC=CC=C1 NTZKNOCUCKBRFH-IBGZPJMESA-N 0.000 description 3
• WVNOFRZQUMORMI-IBGZPJMESA-N (3r)-n-(6-phenylpyrimidin-4-yl)spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound C([C@]1(C2CCN(CC2)C1)O1)N=C1NC(N=CN=1)=CC=1C1=CC=CC=C1 WVNOFRZQUMORMI-IBGZPJMESA-N 0.000 description 3
• BFUZOQOYXKRRCU-SFHVURJKSA-N (3r)-n-(7-methoxyquinoxalin-2-yl)spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound C1N(CC2)CCC2[C@]1(O1)CN=C1NC1=NC2=CC(OC)=CC=C2N=C1 BFUZOQOYXKRRCU-SFHVURJKSA-N 0.000 description 3
• KZQPGEKJMLCKJN-SFHVURJKSA-N (3r)-n-(7-methylquinoxalin-2-yl)spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound C1N(CC2)CCC2[C@]1(O1)CN=C1NC1=NC2=CC(C)=CC=C2N=C1 KZQPGEKJMLCKJN-SFHVURJKSA-N 0.000 description 3
• WMHGQZFNZDLVRU-HNNXBMFYSA-N (3r)-n-([1,3]thiazolo[5,4-b]pyridin-2-yl)spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound C1N(CC2)CCC2[C@]21OC(NC=1SC3=NC=CC=C3N=1)=NC2 WMHGQZFNZDLVRU-HNNXBMFYSA-N 0.000 description 3
• JDVSSCUYTGNWQT-AWEZNQCLSA-N (3r)-n-[5-(difluoromethoxy)pyrimidin-2-yl]spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound N1=CC(OC(F)F)=CN=C1NC(O1)=NC[C@]11C(CC2)CCN2C1 JDVSSCUYTGNWQT-AWEZNQCLSA-N 0.000 description 3
• ZIXIFHSPOBDBRO-ZDUSSCGKSA-N (3r)-n-[5-(trifluoromethyl)pyrazin-2-yl]spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound C1=NC(C(F)(F)F)=CN=C1NC(O1)=NC[C@]11C(CC2)CCN2C1 ZIXIFHSPOBDBRO-ZDUSSCGKSA-N 0.000 description 3
• KXHUDEDKBAKSRV-AWEZNQCLSA-N (3r)-n-[6-(2,2,2-trifluoroethoxy)pyrimidin-4-yl]spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound C1=NC(OCC(F)(F)F)=CC(NC=2O[C@@]3(C4CCN(CC4)C3)CN=2)=N1 KXHUDEDKBAKSRV-AWEZNQCLSA-N 0.000 description 3
• OHJILIYZJFKVAK-SFHVURJKSA-N (3r)-n-[6-(2-methoxypyrimidin-5-yl)pyrimidin-4-yl]spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound C1=NC(OC)=NC=C1C1=CC(NC=2O[C@@]3(C4CCN(CC4)C3)CN=2)=NC=N1 OHJILIYZJFKVAK-SFHVURJKSA-N 0.000 description 3
• YFJQVJATGSDKAJ-IBGZPJMESA-N (3r)-n-[6-(3-chlorophenyl)pyrimidin-4-yl]spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound ClC1=CC=CC(C=2N=CN=C(NC=3O[C@@]4(C5CCN(CC5)C4)CN=3)C=2)=C1 YFJQVJATGSDKAJ-IBGZPJMESA-N 0.000 description 3
• SNBBXZLFADZUSU-SFHVURJKSA-N (3r)-n-[6-(difluoromethoxy)-1-methylindazol-3-yl]spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound C12=CC=C(OC(F)F)C=C2N(C)N=C1NC(O1)=NC[C@]11C(CC2)CCN2C1 SNBBXZLFADZUSU-SFHVURJKSA-N 0.000 description 3
• VBEVNLXGJACWIE-HNNXBMFYSA-N (3r)-n-[6-(methoxymethyl)pyrimidin-4-yl]spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound C1=NC(COC)=CC(NC=2O[C@@]3(C4CCN(CC4)C3)CN=2)=N1 VBEVNLXGJACWIE-HNNXBMFYSA-N 0.000 description 3
• ZDTPXUKLGIDOCS-SFHVURJKSA-N (3r)-n-isoquinolin-3-ylspiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound C1N(CC2)CCC2[C@]21OC(NC=1N=CC3=CC=CC=C3C=1)=NC2 ZDTPXUKLGIDOCS-SFHVURJKSA-N 0.000 description 3
• NMPVAHVZPACQSB-UHFFFAOYSA-N 1,1-bis(methylsulfanyl)-N-pyridin-2-ylmethanimine Chemical compound CSC(SC)=NC1=CC=CC=N1 NMPVAHVZPACQSB-UHFFFAOYSA-N 0.000 description 3
• WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 3
• 125000004214 1-pyrrolidinyl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 3
• MFJBJIDWQXSZHR-UHFFFAOYSA-N 2,3-dichloro-6-isothiocyanatopyridine Chemical compound ClC1=CC=C(N=C=S)N=C1Cl MFJBJIDWQXSZHR-UHFFFAOYSA-N 0.000 description 3
• DAMKLTBYCMQBPW-KRWDZBQOSA-N 2,4-dimethyl-6-[[(3r)-spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-yl]amino]pyridine-3-carbonitrile Chemical compound CC1=C(C#N)C(C)=CC(NC=2O[C@@]3(C4CCN(CC4)C3)CN=2)=N1 DAMKLTBYCMQBPW-KRWDZBQOSA-N 0.000 description 3
• WLHADOSXRICWAB-UHFFFAOYSA-N 2-(difluoromethoxy)-5-nitropyridine Chemical compound [O-][N+](=O)C1=CC=C(OC(F)F)N=C1 WLHADOSXRICWAB-UHFFFAOYSA-N 0.000 description 3
• UDLFPPHYXDHXCU-UHFFFAOYSA-N 2-(spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-ylamino)-1,3-benzothiazol-6-ol Chemical compound C1N(CC2)CCC2C1(O1)CN=C1NC1=NC2=CC=C(O)C=C2S1 UDLFPPHYXDHXCU-UHFFFAOYSA-N 0.000 description 3
• VSOBZMWGTWAHSR-UHFFFAOYSA-N 2-bromo-6-isothiocyanatopyridine Chemical compound BrC1=CC=CC(N=C=S)=N1 VSOBZMWGTWAHSR-UHFFFAOYSA-N 0.000 description 3
• WTSWSBPEZJCSMC-UHFFFAOYSA-N 2-chloro-5-(difluoromethoxy)pyrimidine Chemical compound FC(F)OC1=CN=C(Cl)N=C1 WTSWSBPEZJCSMC-UHFFFAOYSA-N 0.000 description 3
• MANHSBQXHPLZSR-UHFFFAOYSA-N 2-chloro-5-cyclopentyloxypyrimidine Chemical compound C1=NC(Cl)=NC=C1OC1CCCC1 MANHSBQXHPLZSR-UHFFFAOYSA-N 0.000 description 3
• RZAZBVCZBWDSBJ-INIZCTEOSA-N 2-methyl-6-[[(3r)-spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-yl]amino]pyridine-3-carbonitrile Chemical compound C1=C(C#N)C(C)=NC(NC=2O[C@@]3(C4CCN(CC4)C3)CN=2)=C1 RZAZBVCZBWDSBJ-INIZCTEOSA-N 0.000 description 3
• DKHLVVSSFRDDKS-UHFFFAOYSA-N 3,5-dichloro-2-isothiocyanatopyridine Chemical compound ClC1=CN=C(N=C=S)C(Cl)=C1 DKHLVVSSFRDDKS-UHFFFAOYSA-N 0.000 description 3
• 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 description 3
• PFCDPPOYVKKKCP-UHFFFAOYSA-N 4,5-dichloro-2-isothiocyanatopyridine Chemical compound ClC1=CN=C(N=C=S)C=C1Cl PFCDPPOYVKKKCP-UHFFFAOYSA-N 0.000 description 3
• XJPZKYIHCLDXST-UHFFFAOYSA-N 4,6-dichloropyrimidine Chemical compound ClC1=CC(Cl)=NC=N1 XJPZKYIHCLDXST-UHFFFAOYSA-N 0.000 description 3
• IUNZNINLPZAQDM-UHFFFAOYSA-N 4-(3-chlorophenyl)-6-isothiocyanatopyrimidine Chemical compound ClC1=CC=CC(C=2N=CN=C(N=C=S)C=2)=C1 IUNZNINLPZAQDM-UHFFFAOYSA-N 0.000 description 3
• YKDAOJYJASPGDM-UHFFFAOYSA-N 4-(4-chlorophenyl)-6-isothiocyanatopyrimidine Chemical compound C1=CC(Cl)=CC=C1C1=CC(N=C=S)=NC=N1 YKDAOJYJASPGDM-UHFFFAOYSA-N 0.000 description 3
• CJTDPEZNGURNJL-UHFFFAOYSA-N 4-chloro-6-(2,2,2-trifluoroethoxy)pyrimidine Chemical compound FC(F)(F)COC1=CC(Cl)=NC=N1 CJTDPEZNGURNJL-UHFFFAOYSA-N 0.000 description 3
• QOOQUMTZWQEHTR-UHFFFAOYSA-N 4-chloro-6-(methoxymethyl)pyrimidine Chemical compound COCC1=CC(Cl)=NC=N1 QOOQUMTZWQEHTR-UHFFFAOYSA-N 0.000 description 3
• DQHCEDCSEAGFRM-UHFFFAOYSA-N 4-chloro-6-cyclopentyloxypyrimidine Chemical compound C1=NC(Cl)=CC(OC2CCCC2)=N1 DQHCEDCSEAGFRM-UHFFFAOYSA-N 0.000 description 3
• AVRNZAITOUMSPB-UHFFFAOYSA-N 4-propan-2-ylpyrimidin-2-amine Chemical compound CC(C)C1=CC=NC(N)=N1 AVRNZAITOUMSPB-UHFFFAOYSA-N 0.000 description 3
• LULBBYYBHKFKBH-UHFFFAOYSA-N 5,6-dichloropyridin-2-amine Chemical compound NC1=CC=C(Cl)C(Cl)=N1 LULBBYYBHKFKBH-UHFFFAOYSA-N 0.000 description 3
• LWYPLPIJTCQWCF-UHFFFAOYSA-N 5-(difluoromethoxy)-[1,3]thiazolo[5,4-b]pyridin-2-amine Chemical compound C1=C(OC(F)F)N=C2SC(N)=NC2=C1 LWYPLPIJTCQWCF-UHFFFAOYSA-N 0.000 description 3
• ILDRNIDSVAZBMZ-UHFFFAOYSA-N 5-(trifluoromethyl)pyrazin-2-amine Chemical compound NC1=CN=C(C(F)(F)F)C=N1 ILDRNIDSVAZBMZ-UHFFFAOYSA-N 0.000 description 3
• GSCRYWWEBZTTBF-UHFFFAOYSA-N 5-bromo-4-propan-2-ylpyrimidin-2-amine Chemical compound CC(C)C1=NC(N)=NC=C1Br GSCRYWWEBZTTBF-UHFFFAOYSA-N 0.000 description 3
• XGAKNUPZXKPFOS-UHFFFAOYSA-N 5-cyclopentyloxypyrimidin-2-amine Chemical compound C1=NC(N)=NC=C1OC1CCCC1 XGAKNUPZXKPFOS-UHFFFAOYSA-N 0.000 description 3
• LLPVJZMTIYQTGU-UHFFFAOYSA-N 5-methoxy-[1,3]thiazolo[5,4-b]pyridin-2-amine Chemical compound COC1=CC=C2N=C(N)SC2=N1 LLPVJZMTIYQTGU-UHFFFAOYSA-N 0.000 description 3
• KFKXUFHFJAKEKI-UHFFFAOYSA-N 5-methoxy-[1,3]thiazolo[5,4-d]pyrimidin-2-amine Chemical compound COC1=NC=C2N=C(N)SC2=N1 KFKXUFHFJAKEKI-UHFFFAOYSA-N 0.000 description 3
• 239000001640 5-methylquinoxaline Substances 0.000 description 3
• BYMNUSPCTDNOFF-INIZCTEOSA-N 5-n,5-n-dimethyl-2-n-[(3r)-spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-yl]-[1,3]thiazolo[5,4-d]pyrimidine-2,5-diamine Chemical compound C1N(CC2)CCC2[C@]1(O1)CN=C1NC1=NC2=CN=C(N(C)C)N=C2S1 BYMNUSPCTDNOFF-INIZCTEOSA-N 0.000 description 3
• VZKIMVYWEBBKGS-UHFFFAOYSA-N 5-phenylmethoxy-[1,3]thiazolo[5,4-b]pyridin-2-amine Chemical compound N1=C2SC(N)=NC2=CC=C1OCC1=CC=CC=C1 VZKIMVYWEBBKGS-UHFFFAOYSA-N 0.000 description 3
• BAXUDPKGRMMFBV-UHFFFAOYSA-N 5-phenylpyridin-3-amine Chemical compound NC1=CN=CC(C=2C=CC=CC=2)=C1 BAXUDPKGRMMFBV-UHFFFAOYSA-N 0.000 description 3
• XSYBQTMVQZSLGQ-UHFFFAOYSA-N 5-pyrrolidin-1-ylpyrazin-2-amine Chemical compound C1=NC(N)=CN=C1N1CCCC1 XSYBQTMVQZSLGQ-UHFFFAOYSA-N 0.000 description 3
• KQJHSCZATVSGTO-UHFFFAOYSA-N 6-(2,2,2-trifluoroethoxy)pyrimidin-4-amine Chemical compound NC1=CC(OCC(F)(F)F)=NC=N1 KQJHSCZATVSGTO-UHFFFAOYSA-N 0.000 description 3
• ZYQBVXRVGUVSCW-UHFFFAOYSA-N 6-(3-chlorophenyl)pyrimidin-4-amine Chemical compound C1=NC(N)=CC(C=2C=C(Cl)C=CC=2)=N1 ZYQBVXRVGUVSCW-UHFFFAOYSA-N 0.000 description 3
• PUXOOQNLQPZQFB-UHFFFAOYSA-N 6-(difluoromethoxy)-1,3-benzothiazol-2-amine Chemical compound C1=C(OC(F)F)C=C2SC(N)=NC2=C1 PUXOOQNLQPZQFB-UHFFFAOYSA-N 0.000 description 3
• LZPYGFBASUNYEY-UHFFFAOYSA-N 6-(difluoromethoxy)pyridin-3-amine Chemical compound NC1=CC=C(OC(F)F)N=C1 LZPYGFBASUNYEY-UHFFFAOYSA-N 0.000 description 3
• TUWLYFAEAPMOJS-UHFFFAOYSA-N 6-(methoxymethyl)-1h-pyrimidin-4-one Chemical compound COCC1=CC(O)=NC=N1 TUWLYFAEAPMOJS-UHFFFAOYSA-N 0.000 description 3
• ZEEJRACEEDQANN-UHFFFAOYSA-N 6-(methoxymethyl)pyrimidin-4-amine Chemical compound COCC1=CC(N)=NC=N1 ZEEJRACEEDQANN-UHFFFAOYSA-N 0.000 description 3
• IVIXRMWFVKQEBE-UHFFFAOYSA-N 6-cyclopentyloxypyrimidin-4-amine Chemical compound C1=NC(N)=CC(OC2CCCC2)=N1 IVIXRMWFVKQEBE-UHFFFAOYSA-N 0.000 description 3
• JKOGFRGFWFEFNT-UHFFFAOYSA-N 6-fluoro-1h-indazol-3-amine Chemical compound FC1=CC=C2C(N)=NNC2=C1 JKOGFRGFWFEFNT-UHFFFAOYSA-N 0.000 description 3
• VZXLYMCMLMJTEI-UHFFFAOYSA-N 6-phenoxypyrimidin-4-amine Chemical compound C1=NC(N)=CC(OC=2C=CC=CC=2)=N1 VZXLYMCMLMJTEI-UHFFFAOYSA-N 0.000 description 3
• NYXYYBHDSNBGOS-UHFFFAOYSA-N 6-phenylpyrimidin-4-amine Chemical compound C1=NC(N)=CC(C=2C=CC=CC=2)=N1 NYXYYBHDSNBGOS-UHFFFAOYSA-N 0.000 description 3
• LEGHXWSIXMQCGW-UHFFFAOYSA-N 6-pyridin-4-ylpyrimidin-4-amine Chemical compound C1=NC(N)=CC(C=2C=CN=CC=2)=N1 LEGHXWSIXMQCGW-UHFFFAOYSA-N 0.000 description 3
• UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
• 108091003079 Bovine Serum Albumin Proteins 0.000 description 3
• VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 3
• DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
• UUYSQAYUTMLLBO-UHFFFAOYSA-N [1,2,4]triazolo[1,5-a]pyrazin-2-amine Chemical compound C1=NC=CN2N=C(N)N=C21 UUYSQAYUTMLLBO-UHFFFAOYSA-N 0.000 description 3
• NCZQAIFOXJOCFI-UHFFFAOYSA-N [1,2,4]triazolo[4,3-a]pyridin-3-amine Chemical compound C1=CC=CN2C(N)=NN=C21 NCZQAIFOXJOCFI-UHFFFAOYSA-N 0.000 description 3
• 230000004913 activation Effects 0.000 description 3
• HSDAJNMJOMSNEV-UHFFFAOYSA-N benzyl chloroformate Chemical compound ClC(=O)OCC1=CC=CC=C1 HSDAJNMJOMSNEV-UHFFFAOYSA-N 0.000 description 3
• 210000004556 brain Anatomy 0.000 description 3
• 210000003169 central nervous system Anatomy 0.000 description 3
• FKGQRXQOODICAT-UHFFFAOYSA-N di(imidazol-1-yl)methanimine Chemical compound C1=CN=CN1C(=N)N1C=CN=C1 FKGQRXQOODICAT-UHFFFAOYSA-N 0.000 description 3
• 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 3
• 208000035475 disorder Diseases 0.000 description 3
• BDTDECDAHYOJRO-UHFFFAOYSA-N ethyl n-(sulfanylidenemethylidene)carbamate Chemical compound CCOC(=O)N=C=S BDTDECDAHYOJRO-UHFFFAOYSA-N 0.000 description 3
• XFSYPTPQPTXLEF-UHFFFAOYSA-N ethyl n-carbamothioylcarbamate;5-methoxypyridin-2-amine Chemical compound CCOC(=O)NC(N)=S.COC1=CC=C(N)N=C1 XFSYPTPQPTXLEF-UHFFFAOYSA-N 0.000 description 3
• 239000012091 fetal bovine serum Substances 0.000 description 3
• 239000012065 filter cake Substances 0.000 description 3
• IWMQAUYDCYPLFK-UHFFFAOYSA-N furo[3,2-c]pyridin-4-amine Chemical compound NC1=NC=CC2=C1C=CO2 IWMQAUYDCYPLFK-UHFFFAOYSA-N 0.000 description 3
• 238000004128 high performance liquid chromatography Methods 0.000 description 3
• 230000003834 intracellular effect Effects 0.000 description 3
• 238000011068 loading method Methods 0.000 description 3
• 238000005259 measurement Methods 0.000 description 3
• 239000002609 medium Substances 0.000 description 3
• 239000012528 membrane Substances 0.000 description 3
• WSFSSNUMVMOOMR-BJUDXGSMSA-N methanone Chemical compound O=[11CH2] WSFSSNUMVMOOMR-BJUDXGSMSA-N 0.000 description 3
• RPGSTSWVRNPAKP-UHFFFAOYSA-N n-(1,3-benzothiazol-2-yl)imidazole-1-carbothioamide Chemical compound N=1C2=CC=CC=C2SC=1NC(=S)N1C=CN=C1 RPGSTSWVRNPAKP-UHFFFAOYSA-N 0.000 description 3
• VUSUESCSIUWQMT-UHFFFAOYSA-N n-(1,3-benzothiazol-2-yl)spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound C1N(CC2)CCC2C21OC(NC=1SC3=CC=CC=C3N=1)=NC2 VUSUESCSIUWQMT-UHFFFAOYSA-N 0.000 description 3
• XMJSRIGSOQCHNI-UHFFFAOYSA-N n-(1,3-thiazol-2-yl)imidazole-1-carbothioamide Chemical compound C1=CN=CN1C(=S)NC1=NC=CS1 XMJSRIGSOQCHNI-UHFFFAOYSA-N 0.000 description 3
• FPSMMDVUWCGKIR-UHFFFAOYSA-N n-(1-methylbenzimidazol-2-yl)imidazole-1-carbothioamide Chemical compound N=1C2=CC=CC=C2N(C)C=1NC(=S)N1C=CN=C1 FPSMMDVUWCGKIR-UHFFFAOYSA-N 0.000 description 3
• RWIHECXZMGLBKP-UHFFFAOYSA-N n-(1-methylbenzimidazol-2-yl)spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound C1=CC=C2N(C)C(NC=3OC4(C5CCN(CC5)C4)CN=3)=NC2=C1 RWIHECXZMGLBKP-UHFFFAOYSA-N 0.000 description 3
• CWFZHFCDHUUVQO-UHFFFAOYSA-N n-(1h-benzimidazol-2-yl)imidazole-1-carbothioamide Chemical compound N=1C2=CC=CC=C2NC=1NC(=S)N1C=CN=C1 CWFZHFCDHUUVQO-UHFFFAOYSA-N 0.000 description 3
• PEOGXBWZFJKISZ-UHFFFAOYSA-N n-(1h-benzimidazol-2-yl)spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound C1N(CC2)CCC2C21OC(NC=1NC3=CC=CC=C3N=1)=NC2 PEOGXBWZFJKISZ-UHFFFAOYSA-N 0.000 description 3
• KYEKKLZQGRIPLQ-UHFFFAOYSA-N n-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)imidazole-1-carbothioamide Chemical compound N=1C=2CCCCC=2SC=1NC(=S)N1C=CN=C1 KYEKKLZQGRIPLQ-UHFFFAOYSA-N 0.000 description 3
• YPYBXVUXWWJIND-UHFFFAOYSA-N n-(4-chloro-1,3-benzothiazol-2-yl)imidazole-1-carbothioamide Chemical compound N=1C=2C(Cl)=CC=CC=2SC=1NC(=S)N1C=CN=C1 YPYBXVUXWWJIND-UHFFFAOYSA-N 0.000 description 3
• OMNHZKWWQQBAMJ-UHFFFAOYSA-N n-(4-chloro-1,3-benzothiazol-2-yl)spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound C1N(CC2)CCC2C1(O1)CN=C1NC(S1)=NC2=C1C=CC=C2Cl OMNHZKWWQQBAMJ-UHFFFAOYSA-N 0.000 description 3
• NOALOJGCCOIRFR-UHFFFAOYSA-N n-(4-methyl-1,3-benzothiazol-2-yl)imidazole-1-carbothioamide Chemical compound N=1C=2C(C)=CC=CC=2SC=1NC(=S)N1C=CN=C1 NOALOJGCCOIRFR-UHFFFAOYSA-N 0.000 description 3
• OXMVTMRZGPMPEJ-UHFFFAOYSA-N n-(4-methyl-1,3-benzothiazol-2-yl)spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound C1N(CC2)CCC2C1(O1)CN=C1NC(S1)=NC2=C1C=CC=C2C OXMVTMRZGPMPEJ-UHFFFAOYSA-N 0.000 description 3
• LPCWBIDEYNTTTN-UHFFFAOYSA-N n-(4-propan-2-yl-1,3-thiazol-2-yl)imidazole-1-carbothioamide Chemical compound CC(C)C1=CSC(NC(=S)N2C=NC=C2)=N1 LPCWBIDEYNTTTN-UHFFFAOYSA-N 0.000 description 3
• MTIALXJECNTTKZ-UHFFFAOYSA-N n-(5,6-dichloropyridin-2-yl)-2,2-dimethylpropanamide Chemical compound CC(C)(C)C(=O)NC1=CC=C(Cl)C(Cl)=N1 MTIALXJECNTTKZ-UHFFFAOYSA-N 0.000 description 3
• RSAYOWHRLDBGBO-UHFFFAOYSA-N n-(5-ethyl-1,3,4-oxadiazol-2-yl)-1,1-bis(methylsulfanyl)methanimine Chemical compound CCC1=NN=C(N=C(SC)SC)O1 RSAYOWHRLDBGBO-UHFFFAOYSA-N 0.000 description 3
• KQOOSJRLDUUAGK-UHFFFAOYSA-N n-(6-bromopyridin-2-yl)spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound BrC1=CC=CC(NC=2OC3(C4CCN(CC4)C3)CN=2)=N1 KQOOSJRLDUUAGK-UHFFFAOYSA-N 0.000 description 3
• VWTRVYZJIAPBHR-UHFFFAOYSA-N n-(6-chloro-1,3-benzothiazol-2-yl)imidazole-1-carbothioamide Chemical compound S1C2=CC(Cl)=CC=C2N=C1NC(=S)N1C=CN=C1 VWTRVYZJIAPBHR-UHFFFAOYSA-N 0.000 description 3
• JFPMKTAXLLHMRR-UHFFFAOYSA-N n-(6-chloro-1,3-benzothiazol-2-yl)spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound C1N(CC2)CCC2C1(O1)CN=C1NC1=NC2=CC=C(Cl)C=C2S1 JFPMKTAXLLHMRR-UHFFFAOYSA-N 0.000 description 3
• KIDXXFXVPLATJJ-UHFFFAOYSA-N n-(6-methoxy-1,3-benzothiazol-2-yl)spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound C1N(CC2)CCC2C1(O1)CN=C1NC1=NC2=CC=C(OC)C=C2S1 KIDXXFXVPLATJJ-UHFFFAOYSA-N 0.000 description 3
• AJVYWPXCDQCOEU-UHFFFAOYSA-N n-(6-methyl-1,3-benzothiazol-2-yl)imidazole-1-carbothioamide Chemical compound S1C2=CC(C)=CC=C2N=C1NC(=S)N1C=CN=C1 AJVYWPXCDQCOEU-UHFFFAOYSA-N 0.000 description 3
• KOHDBHPGUHPVRI-UHFFFAOYSA-N n-(6-methyl-1,3-benzothiazol-2-yl)spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound C1N(CC2)CCC2C1(O1)CN=C1NC1=NC2=CC=C(C)C=C2S1 KOHDBHPGUHPVRI-UHFFFAOYSA-N 0.000 description 3
• CBUFXFPZRODFOI-UHFFFAOYSA-N n-[(2,4-dimethoxyphenyl)methyl]-6-methylquinoxalin-2-amine Chemical compound COC1=CC(OC)=CC=C1CNC1=CN=C(C=C(C)C=C2)C2=N1 CBUFXFPZRODFOI-UHFFFAOYSA-N 0.000 description 3
• PMMRCUFGSCVKGZ-UHFFFAOYSA-N n-[(2,4-dimethoxyphenyl)methyl]-7-methylquinoxalin-2-amine Chemical compound COC1=CC(OC)=CC=C1CNC1=CN=C(C=CC(C)=C2)C2=N1 PMMRCUFGSCVKGZ-UHFFFAOYSA-N 0.000 description 3
• LRAMDZDYWGJMGU-UHFFFAOYSA-N n-[2-(imidazole-1-carbothioylamino)-1,3-benzothiazol-6-yl]acetamide Chemical compound S1C2=CC(NC(=O)C)=CC=C2N=C1NC(=S)N1C=CN=C1 LRAMDZDYWGJMGU-UHFFFAOYSA-N 0.000 description 3
• XXIXRNVGOZQCDX-UHFFFAOYSA-N n-[5-(difluoromethoxy)-[1,3]thiazolo[5,4-b]pyridin-2-yl]imidazole-1-carbothioamide Chemical compound S1C2=NC(OC(F)F)=CC=C2N=C1NC(=S)N1C=CN=C1 XXIXRNVGOZQCDX-UHFFFAOYSA-N 0.000 description 3
• YBDKBVGKMUKXGV-UHFFFAOYSA-N n-[6-(difluoromethoxy)-1,3-benzothiazol-2-yl]imidazole-1-carbothioamide Chemical compound S1C2=CC(OC(F)F)=CC=C2N=C1NC(=S)N1C=CN=C1 YBDKBVGKMUKXGV-UHFFFAOYSA-N 0.000 description 3
• KYMBMYMZVKUDDV-UHFFFAOYSA-N n-[6-[tert-butyl(dimethyl)silyl]oxy-1,3-benzothiazol-2-yl]imidazole-1-carbothioamide Chemical compound S1C2=CC(O[Si](C)(C)C(C)(C)C)=CC=C2N=C1NC(=S)N1C=CN=C1 KYMBMYMZVKUDDV-UHFFFAOYSA-N 0.000 description 3
• 229960002715 nicotine Drugs 0.000 description 3
• SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 3
• MUJIDPITZJWBSW-UHFFFAOYSA-N palladium(2+) Chemical compound [Pd+2] MUJIDPITZJWBSW-UHFFFAOYSA-N 0.000 description 3
• 239000000137 peptide hydrolase inhibitor Substances 0.000 description 3
• HXITXNWTGFUOAU-UHFFFAOYSA-N phenylboronic acid Chemical compound OB(O)C1=CC=CC=C1 HXITXNWTGFUOAU-UHFFFAOYSA-N 0.000 description 3
• BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 3
• 125000004307 pyrazin-2-yl group Chemical group [H]C1=C([H])N=C(*)C([H])=N1 0.000 description 3
• 230000000698 schizophrenic effect Effects 0.000 description 3
• 229910052708 sodium Inorganic materials 0.000 description 3
• CBNWMAMNZGMMAU-UHFFFAOYSA-N spiro[1-azabicyclo[2.2.2]octane-3,4'-5h-1,3-oxazole]-2'-amine Chemical compound C1OC(N)=NC21C(CC1)CCN1C2 CBNWMAMNZGMMAU-UHFFFAOYSA-N 0.000 description 3
• 239000000126 substance Substances 0.000 description 3
• 238000003786 synthesis reaction Methods 0.000 description 3
• 238000002560 therapeutic procedure Methods 0.000 description 3
• LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 3
• DOMQFIFVDIAOOT-ROUUACIJSA-N (2S,3R)-N-[4-(2,6-dimethoxyphenyl)-5-(5-methylpyridin-3-yl)-1,2,4-triazol-3-yl]-3-(5-methylpyrimidin-2-yl)butane-2-sulfonamide Chemical compound COC1=C(C(=CC=C1)OC)N1C(=NN=C1C=1C=NC=C(C=1)C)NS(=O)(=O)[C@@H](C)[C@H](C)C1=NC=C(C=N1)C DOMQFIFVDIAOOT-ROUUACIJSA-N 0.000 description 2
• AVLCTLDGDXTCNZ-FQEVSTJZSA-N (3r)-n-(2-phenylpyridin-4-yl)spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound C([C@]1(C2CCN(CC2)C1)O1)N=C1NC(C=1)=CC=NC=1C1=CC=CC=C1 AVLCTLDGDXTCNZ-FQEVSTJZSA-N 0.000 description 2
• XXCHCVVLHLOEDV-AWEZNQCLSA-N (3r)-n-(4,5-dichloropyridin-2-yl)spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound C1=C(Cl)C(Cl)=CN=C1NC(O1)=NC[C@]11C(CC2)CCN2C1 XXCHCVVLHLOEDV-AWEZNQCLSA-N 0.000 description 2
• USOMYWQXRPHQQC-SFHVURJKSA-N (3r)-n-(5-bromo-4-pyridin-3-ylpyrimidin-2-yl)spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound BrC1=CN=C(NC=2O[C@@]3(C4CCN(CC4)C3)CN=2)N=C1C1=CC=CN=C1 USOMYWQXRPHQQC-SFHVURJKSA-N 0.000 description 2
• AKERCGDVAZEUON-HNNXBMFYSA-N (3r)-n-(5-chloro-4-methylpyridin-2-yl)spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound C1=C(Cl)C(C)=CC(NC=2O[C@@]3(C4CCN(CC4)C3)CN=2)=N1 AKERCGDVAZEUON-HNNXBMFYSA-N 0.000 description 2
• DGEIXJTUYSVCBC-HNNXBMFYSA-N (3r)-n-(5-methoxy-[1,3]thiazolo[5,4-d]pyrimidin-2-yl)spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound C1N(CC2)CCC2[C@]1(O1)CN=C1NC1=NC2=CN=C(OC)N=C2S1 DGEIXJTUYSVCBC-HNNXBMFYSA-N 0.000 description 2
• PIFLATPNVAJZIA-SFHVURJKSA-N (3r)-n-(5-pyridin-3-ylpyrazin-2-yl)spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound C([C@]1(C2CCN(CC2)C1)O1)N=C1NC(N=C1)=CN=C1C1=CC=CN=C1 PIFLATPNVAJZIA-SFHVURJKSA-N 0.000 description 2
• ARRIQLFAOHIHOY-INIZCTEOSA-N (3r)-n-(6-methoxy-[1,2,4]triazolo[1,5-a]pyridin-2-yl)spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound C1N(CC2)CCC2[C@]1(O1)CN=C1NC1=NN(C=C(OC)C=C2)C2=N1 ARRIQLFAOHIHOY-INIZCTEOSA-N 0.000 description 2
• FUAGQZJUHOGUOV-HNNXBMFYSA-N (3r)-n-(6-methylsulfanyl-[1,3]thiazolo[4,5-b]pyrazin-2-yl)spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound C1N(CC2)CCC2[C@]1(O1)CN=C1NC1=NC2=NC=C(SC)N=C2S1 FUAGQZJUHOGUOV-HNNXBMFYSA-N 0.000 description 2
• YUSCNUFLONHFOI-FQEVSTJZSA-N (3r)-n-(6-phenylpyridin-2-yl)spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound C([C@]1(C2CCN(CC2)C1)O1)N=C1NC(N=1)=CC=CC=1C1=CC=CC=C1 YUSCNUFLONHFOI-FQEVSTJZSA-N 0.000 description 2
• QZJJQKHTYOGWRZ-IBGZPJMESA-N (3r)-n-(6-propan-2-yloxy-1,3-benzothiazol-2-yl)spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound C1N(CC2)CCC2[C@]1(O1)CN=C1NC1=NC2=CC=C(OC(C)C)C=C2S1 QZJJQKHTYOGWRZ-IBGZPJMESA-N 0.000 description 2
• WLYKLHKTDTYDLH-INIZCTEOSA-N (3r)-n-(6-propan-2-yloxypyrimidin-4-yl)spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound C1=NC(OC(C)C)=CC(NC=2O[C@@]3(C4CCN(CC4)C3)CN=2)=N1 WLYKLHKTDTYDLH-INIZCTEOSA-N 0.000 description 2
• FTZDQURZBJNTLV-IBGZPJMESA-N (3r)-n-[5-(6-methoxypyridin-3-yl)pyrazin-2-yl]spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound C1=NC(OC)=CC=C1C(N=C1)=CN=C1NC(O1)=NC[C@]11C(CC2)CCN2C1 FTZDQURZBJNTLV-IBGZPJMESA-N 0.000 description 2
• XEHLPXIKSPZCIB-INIZCTEOSA-N (3r)-n-[5-(difluoromethoxy)-[1,3]thiazolo[5,4-b]pyridin-2-yl]spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound C1N(CC2)CCC2[C@]1(O1)CN=C1NC1=NC2=CC=C(OC(F)F)N=C2S1 XEHLPXIKSPZCIB-INIZCTEOSA-N 0.000 description 2
• MZAIGRWVEVWXNO-HNNXBMFYSA-N (3r)-n-[6-(2,2-difluoroethoxy)pyrimidin-4-yl]spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound C1=NC(OCC(F)F)=CC(NC=2O[C@@]3(C4CCN(CC4)C3)CN=2)=N1 MZAIGRWVEVWXNO-HNNXBMFYSA-N 0.000 description 2
• OKRKJTZZVNOCII-IBGZPJMESA-N (3r)-n-[6-(4-chlorophenyl)pyrimidin-4-yl]spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound C1=CC(Cl)=CC=C1C1=CC(NC=2O[C@@]3(C4CCN(CC4)C3)CN=2)=NC=N1 OKRKJTZZVNOCII-IBGZPJMESA-N 0.000 description 2
• LETXCYWPGGCZGQ-FQEVSTJZSA-N (3r)-n-[6-(4-methoxyphenyl)pyrimidin-4-yl]spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound C1=CC(OC)=CC=C1C1=CC(NC=2O[C@@]3(C4CCN(CC4)C3)CN=2)=NC=N1 LETXCYWPGGCZGQ-FQEVSTJZSA-N 0.000 description 2
• UXOWDLFCRVKBGS-IBGZPJMESA-N (3r)-n-[6-(6-methoxypyridin-3-yl)pyrimidin-4-yl]spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound C1=NC(OC)=CC=C1C1=CC(NC=2O[C@@]3(C4CCN(CC4)C3)CN=2)=NC=N1 UXOWDLFCRVKBGS-IBGZPJMESA-N 0.000 description 2
• WOJCVPHCTJFPKM-KRWDZBQOSA-N (3r)-n-[6-(difluoromethoxy)-1,3-benzothiazol-2-yl]spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound C1N(CC2)CCC2[C@]1(O1)CN=C1NC1=NC2=CC=C(OC(F)F)C=C2S1 WOJCVPHCTJFPKM-KRWDZBQOSA-N 0.000 description 2
• IMMCHFLTBDORJH-INIZCTEOSA-N (3r)-n-furo[3,2-c]pyridin-4-ylspiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound C1N(CC2)CCC2[C@]21OC(NC=1C=3C=COC=3C=CN=1)=NC2 IMMCHFLTBDORJH-INIZCTEOSA-N 0.000 description 2
• NWOGQPOGFKBIMN-AWEZNQCLSA-N (3r)-n-pyridin-2-ylspiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound C([C@]1(C2CCN(CC2)C1)O1)N=C1NC1=CC=CC=N1 NWOGQPOGFKBIMN-AWEZNQCLSA-N 0.000 description 2
• FGGUQMSYRSJAII-AWEZNQCLSA-N (3r)-n-pyridin-4-ylspiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound C([C@]1(C2CCN(CC2)C1)O1)N=C1NC1=CC=NC=C1 FGGUQMSYRSJAII-AWEZNQCLSA-N 0.000 description 2
• VEGLDOGYVHCXAC-UHFFFAOYSA-N 1,1-bis(methylsulfanyl)-n-(3-methyl-1,2,4-thiadiazol-5-yl)methanimine Chemical compound CSC(SC)=NC1=NC(C)=NS1 VEGLDOGYVHCXAC-UHFFFAOYSA-N 0.000 description 2
• FIBFRSFPAIRFOR-UHFFFAOYSA-N 1-(5-aminopyrazin-2-yl)pyrrolidin-2-one Chemical compound C1=NC(N)=CN=C1N1C(=O)CCC1 FIBFRSFPAIRFOR-UHFFFAOYSA-N 0.000 description 2
• OKGNEHOXHXVIMK-KRWDZBQOSA-N 1-[5-[[(3r)-spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-yl]amino]pyrazin-2-yl]pyrrolidin-2-one Chemical compound O=C1CCCN1C(N=C1)=CN=C1NC(O1)=NC[C@]11C(CC2)CCN2C1 OKGNEHOXHXVIMK-KRWDZBQOSA-N 0.000 description 2
• VEAWPMXEROMSKF-HNNXBMFYSA-N 2-[[(3r)-spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-yl]amino]-4h-[1,3]thiazolo[5,4-b]pyridin-5-one Chemical compound C1N(CC2)CCC2[C@]1(O1)CN=C1NC1=NC(C=CC(N2)=O)=C2S1 VEAWPMXEROMSKF-HNNXBMFYSA-N 0.000 description 2
• SXUWYCHACCYVMS-UHFFFAOYSA-N 2-chloro-6-methoxyquinoxaline Chemical compound N1=C(Cl)C=NC2=CC(OC)=CC=C21 SXUWYCHACCYVMS-UHFFFAOYSA-N 0.000 description 2
• BOGPIHXNWPTGNH-UHFFFAOYSA-N 2-chloropyrimidin-5-ol Chemical compound OC1=CN=C(Cl)N=C1 BOGPIHXNWPTGNH-UHFFFAOYSA-N 0.000 description 2
• UONKGCZCROZZCD-UHFFFAOYSA-N 3-(aminomethyl)-1-azabicyclo[2.2.2]octan-3-ol Chemical compound C1CC2C(CN)(O)CN1CC2 UONKGCZCROZZCD-UHFFFAOYSA-N 0.000 description 2
• MQTXWBGYHOTVHZ-UHFFFAOYSA-N 3-bromo-6-isothiocyanatopyridazine Chemical compound BrC1=CC=C(N=C=S)N=N1 MQTXWBGYHOTVHZ-UHFFFAOYSA-N 0.000 description 2
• OHOUDXWKMDOAPQ-UHFFFAOYSA-N 3-chloro-6-isothiocyanatopyridazine Chemical compound ClC1=CC=C(N=C=S)N=N1 OHOUDXWKMDOAPQ-UHFFFAOYSA-N 0.000 description 2
• UGMQFWDSELPKKP-UHFFFAOYSA-N 3-isothiocyanatoisoquinoline Chemical compound C1=CC=C2C=NC(N=C=S)=CC2=C1 UGMQFWDSELPKKP-UHFFFAOYSA-N 0.000 description 2
• IELZPOFKHRZRGS-UHFFFAOYSA-N 4,5-dimethylpyrimidin-2-amine Chemical compound CC1=CN=C(N)N=C1C IELZPOFKHRZRGS-UHFFFAOYSA-N 0.000 description 2
• IPBKLPYWVRTALX-UHFFFAOYSA-N 5-methylsulfanylpyrazin-2-amine Chemical compound CSC1=CN=C(N)C=N1 IPBKLPYWVRTALX-UHFFFAOYSA-N 0.000 description 2
• SJGNIZFAJDLNQE-UHFFFAOYSA-N 5-pyridin-3-ylpyrazin-2-amine Chemical compound C1=NC(N)=CN=C1C1=CC=CN=C1 SJGNIZFAJDLNQE-UHFFFAOYSA-N 0.000 description 2
• AJWURYOLKGMWBS-UHFFFAOYSA-N 6-(2-methoxypyrimidin-5-yl)pyrimidin-4-amine Chemical compound C1=NC(OC)=NC=C1C1=CC(N)=NC=N1 AJWURYOLKGMWBS-UHFFFAOYSA-N 0.000 description 2
• TUABPDBZFQJDHM-UHFFFAOYSA-N 6-(3-methoxyphenyl)pyrimidin-4-amine Chemical compound COC1=CC=CC(C=2N=CN=C(N)C=2)=C1 TUABPDBZFQJDHM-UHFFFAOYSA-N 0.000 description 2
• LHRMIXPETPBOOD-UHFFFAOYSA-N 6-(difluoromethoxy)-1-methylindazol-3-amine Chemical compound C1=C(OC(F)F)C=C2N(C)N=C(N)C2=C1 LHRMIXPETPBOOD-UHFFFAOYSA-N 0.000 description 2
• BKLJUYPLUWUEOQ-UHFFFAOYSA-N 6-bromopyridin-2-amine Chemical compound NC1=CC=CC(Br)=N1 BKLJUYPLUWUEOQ-UHFFFAOYSA-N 0.000 description 2
• YUGIDNINXCKSJH-UHFFFAOYSA-N 6-methoxyquinoxalin-2-amine Chemical compound N1=C(N)C=NC2=CC(OC)=CC=C21 YUGIDNINXCKSJH-UHFFFAOYSA-N 0.000 description 2
• GVERQUMLAYWTMA-UHFFFAOYSA-N 7-methoxy-1h-quinoxalin-2-one Chemical compound N1=CC(O)=NC2=CC(OC)=CC=C21 GVERQUMLAYWTMA-UHFFFAOYSA-N 0.000 description 2
• DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 2
• QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
• QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
• XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
• UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
• ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
• 102000004980 Dopamine D2 Receptors Human genes 0.000 description 2
• 108090001111 Dopamine D2 Receptors Proteins 0.000 description 2
• OUVXYXNWSVIOSJ-UHFFFAOYSA-N Fluo-4 Chemical compound CC1=CC=C(N(CC(O)=O)CC(O)=O)C(OCCOC=2C(=CC=C(C=2)C2=C3C=C(F)C(=O)C=C3OC3=CC(O)=C(F)C=C32)N(CC(O)=O)CC(O)=O)=C1 OUVXYXNWSVIOSJ-UHFFFAOYSA-N 0.000 description 2
• UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
• SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical group C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
• TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
• DBTDEFJAFBUGPP-UHFFFAOYSA-N Methanethial Chemical compound S=C DBTDEFJAFBUGPP-UHFFFAOYSA-N 0.000 description 2
• JRNVZBWKYDBUCA-UHFFFAOYSA-N N-chlorosuccinimide Chemical compound ClN1C(=O)CCC1=O JRNVZBWKYDBUCA-UHFFFAOYSA-N 0.000 description 2
• ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical group C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 description 2
• ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
• GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
• 208000028017 Psychotic disease Diseases 0.000 description 2
• KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical group C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 description 2
• JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
• SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical group N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
• KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 2
• QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
• 239000007983 Tris buffer Substances 0.000 description 2
• DACWQSNZECJJGG-UHFFFAOYSA-N [1,2,4]triazolo[1,5-a]pyridine Chemical group C1=CC=CN2N=CN=C21 DACWQSNZECJJGG-UHFFFAOYSA-N 0.000 description 2
• 239000002253 acid Substances 0.000 description 2
• 235000019270 ammonium chloride Nutrition 0.000 description 2
• 239000000164 antipsychotic agent Substances 0.000 description 2
• 230000003935 attention Effects 0.000 description 2
• 230000006399 behavior Effects 0.000 description 2
• 230000008901 benefit Effects 0.000 description 2
• IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical group C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 description 2
• 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 description 2
• 230000015572 biosynthetic process Effects 0.000 description 2
• UORVGPXVDQYIDP-BJUDXGSMSA-N borane Chemical group [10BH3] UORVGPXVDQYIDP-BJUDXGSMSA-N 0.000 description 2
• 230000005587 bubbling Effects 0.000 description 2
• 239000011575 calcium Substances 0.000 description 2
• 239000001110 calcium chloride Substances 0.000 description 2
• 229910001628 calcium chloride Inorganic materials 0.000 description 2
• 235000011148 calcium chloride Nutrition 0.000 description 2
• 208000010877 cognitive disease Diseases 0.000 description 2
• 239000013078 crystal Substances 0.000 description 2
• 125000000753 cycloalkyl group Chemical group 0.000 description 2
• 238000007405 data analysis Methods 0.000 description 2
• 230000006866 deterioration Effects 0.000 description 2
• 125000004786 difluoromethoxy group Chemical group [H]C(F)(F)O* 0.000 description 2
• BGRWYRAHAFMIBJ-UHFFFAOYSA-N diisopropylcarbodiimide Natural products CC(C)NC(=O)NC(C)C BGRWYRAHAFMIBJ-UHFFFAOYSA-N 0.000 description 2
• 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 2
• VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
• 230000008030 elimination Effects 0.000 description 2
• 238000003379 elimination reaction Methods 0.000 description 2
• 238000003821 enantio-separation Methods 0.000 description 2
• 230000007613 environmental effect Effects 0.000 description 2
• 150000002148 esters Chemical class 0.000 description 2
• FKZUMAMNRPWLKP-UHFFFAOYSA-N ethyl n-[5-(dimethylamino)-[1,3]thiazolo[5,4-d]pyrimidin-2-yl]carbamate Chemical compound N1=C(N(C)C)N=C2SC(NC(=O)OCC)=NC2=C1 FKZUMAMNRPWLKP-UHFFFAOYSA-N 0.000 description 2
• 239000000284 extract Substances 0.000 description 2
• 230000006870 function Effects 0.000 description 2
• 230000002068 genetic effect Effects 0.000 description 2
• 125000004438 haloalkoxy group Chemical group 0.000 description 2
• 229910052736 halogen Inorganic materials 0.000 description 2
• 150000002367 halogens Chemical group 0.000 description 2
• 125000005241 heteroarylamino group Chemical group 0.000 description 2
• 210000001320 hippocampus Anatomy 0.000 description 2
• IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine hydrate Chemical compound O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 2
• 150000002430 hydrocarbons Chemical group 0.000 description 2
• 150000002431 hydrogen Chemical class 0.000 description 2
• XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 2
• 238000005984 hydrogenation reaction Methods 0.000 description 2
• NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 2
• 239000005457 ice water Substances 0.000 description 2
• AWJUIBRHMBBTKR-UHFFFAOYSA-N isoquinoline Chemical group C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 description 2
• 150000002576 ketones Chemical class 0.000 description 2
• 238000004519 manufacturing process Methods 0.000 description 2
• 238000004949 mass spectrometry Methods 0.000 description 2
• 230000006386 memory function Effects 0.000 description 2
• YKBNMVULSUSZJK-UHFFFAOYSA-N n-(1,3-thiazol-2-yl)spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound O1C2(C3CCN(CC3)C2)CN=C1NC1=NC=CS1 YKBNMVULSUSZJK-UHFFFAOYSA-N 0.000 description 2
• MDSDFKBIYXYXNF-UHFFFAOYSA-N n-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound C1N(CC2)CCC2C21OC(NC=1SC=3CCCCC=3N=1)=NC2 MDSDFKBIYXYXNF-UHFFFAOYSA-N 0.000 description 2
• LUMIIFRRDJKEKE-UHFFFAOYSA-N n-(4-propan-2-yl-1,3-thiazol-2-yl)spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound CC(C)C1=CSC(NC=2OC3(C4CCN(CC4)C3)CN=2)=N1 LUMIIFRRDJKEKE-UHFFFAOYSA-N 0.000 description 2
• LSVLHXBLFBHBCC-UHFFFAOYSA-N n-(5-methoxy-[1,3]thiazolo[5,4-b]pyridin-2-yl)spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound C1N(CC2)CCC2C1(O1)CN=C1NC1=NC2=CC=C(OC)N=C2S1 LSVLHXBLFBHBCC-UHFFFAOYSA-N 0.000 description 2
• CXQLQGQCIQXZMI-UHFFFAOYSA-N n-(5-methyl-1,3,4-oxadiazol-2-yl)-1,1-bis(methylsulfanyl)methanimine Chemical compound CSC(SC)=NC1=NN=C(C)O1 CXQLQGQCIQXZMI-UHFFFAOYSA-N 0.000 description 2
• NBUYLEPFONRQCZ-UHFFFAOYSA-N n-(5-phenyl-1,3-thiazol-2-yl)spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound O1C2(C3CCN(CC3)C2)CN=C1NC(S1)=NC=C1C1=CC=CC=C1 NBUYLEPFONRQCZ-UHFFFAOYSA-N 0.000 description 2
• URWMDWYEUVQFRS-UHFFFAOYSA-N n-(6-bromo-[1,3]thiazolo[4,5-b]pyrazin-2-yl)-1,1-bis(methylsulfanyl)methanimine Chemical compound C1=C(Br)N=C2SC(N=C(SC)SC)=NC2=N1 URWMDWYEUVQFRS-UHFFFAOYSA-N 0.000 description 2
• RYFJHYNEJKFKIE-UHFFFAOYSA-N n-(6-ethoxy-1,3-benzothiazol-2-yl)imidazole-1-carbothioamide Chemical compound S1C2=CC(OCC)=CC=C2N=C1NC(=S)N1C=CN=C1 RYFJHYNEJKFKIE-UHFFFAOYSA-N 0.000 description 2
• DYYIGENAVULQMH-UHFFFAOYSA-N n-(6-ethoxy-1,3-benzothiazol-2-yl)spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound C1N(CC2)CCC2C1(O1)CN=C1NC1=NC2=CC=C(OCC)C=C2S1 DYYIGENAVULQMH-UHFFFAOYSA-N 0.000 description 2
• FQXJYXQXFVMXOQ-UHFFFAOYSA-N n-(6-methoxy-1,3-benzothiazol-2-yl)imidazole-1-carbothioamide Chemical compound S1C2=CC(OC)=CC=C2N=C1NC(=S)N1C=CN=C1 FQXJYXQXFVMXOQ-UHFFFAOYSA-N 0.000 description 2
• PRRHVBDGWWFSRJ-SFHVURJKSA-N n-[2-[[(3r)-spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-yl]amino]-1,3-benzothiazol-6-yl]acetamide Chemical compound C1N(CC2)CCC2[C@]1(O1)CN=C1NC1=NC2=CC=C(NC(=O)C)C=C2S1 PRRHVBDGWWFSRJ-SFHVURJKSA-N 0.000 description 2
• WWBYXUSUDJVAED-UHFFFAOYSA-N n-[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound C1=CC(OC)=CC=C1C1=CSC(NC=2OC3(C4CCN(CC4)C3)CN=2)=N1 WWBYXUSUDJVAED-UHFFFAOYSA-N 0.000 description 2
• NPLRRFUPFJMICF-UHFFFAOYSA-N n-[4-(4-methoxyphenyl)-5-methyl-1,3-thiazol-2-yl]imidazole-1-carbothioamide Chemical compound C1=CC(OC)=CC=C1C1=C(C)SC(NC(=S)N2C=NC=C2)=N1 NPLRRFUPFJMICF-UHFFFAOYSA-N 0.000 description 2
• OZEMQJOXYRKPEG-UHFFFAOYSA-N n-[4-(4-methoxyphenyl)-5-methyl-1,3-thiazol-2-yl]spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound C1=CC(OC)=CC=C1C1=C(C)SC(NC=2OC3(C4CCN(CC4)C3)CN=2)=N1 OZEMQJOXYRKPEG-UHFFFAOYSA-N 0.000 description 2
• LZNSBKRVTSLHIE-UHFFFAOYSA-N n-[5-(4-methoxyphenyl)-1,3-thiazol-2-yl]imidazole-1-carbothioamide Chemical compound C1=CC(OC)=CC=C1C(S1)=CN=C1NC(=S)N1C=NC=C1 LZNSBKRVTSLHIE-UHFFFAOYSA-N 0.000 description 2
• NWOGQPOGFKBIMN-UHFFFAOYSA-N n-pyridin-2-ylspiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound O1C2(C3CCN(CC3)C2)CN=C1NC1=CC=CC=N1 NWOGQPOGFKBIMN-UHFFFAOYSA-N 0.000 description 2
• KEEAZYDQOLFVOL-UHFFFAOYSA-N n-pyridin-3-ylspiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound O1C2(C3CCN(CC3)C2)CN\C1=N/C1=CC=CN=C1 KEEAZYDQOLFVOL-UHFFFAOYSA-N 0.000 description 2
• 239000000546 pharmaceutical excipient Substances 0.000 description 2
• 230000000144 pharmacologic effect Effects 0.000 description 2
• 238000002953 preparative HPLC Methods 0.000 description 2
• 208000020016 psychiatric disease Diseases 0.000 description 2
• ABMYEXAYWZJVOV-UHFFFAOYSA-N pyridin-3-ylboronic acid Chemical compound OB(O)C1=CC=CN=C1 ABMYEXAYWZJVOV-UHFFFAOYSA-N 0.000 description 2
• 125000004527 pyrimidin-4-yl group Chemical group N1=CN=C(C=C1)* 0.000 description 2
• 238000011002 quantification Methods 0.000 description 2
• XSCHRSMBECNVNS-UHFFFAOYSA-N quinoxaline Chemical group N1=CC=NC2=CC=CC=C21 XSCHRSMBECNVNS-UHFFFAOYSA-N 0.000 description 2
• 230000009467 reduction Effects 0.000 description 2
• 230000004044 response Effects 0.000 description 2
• 238000012552 review Methods 0.000 description 2
• 239000000779 smoke Substances 0.000 description 2
• WRIKHQLVHPKCJU-UHFFFAOYSA-N sodium bis(trimethylsilyl)amide Chemical compound C[Si](C)(C)N([Na])[Si](C)(C)C WRIKHQLVHPKCJU-UHFFFAOYSA-N 0.000 description 2
• 239000012312 sodium hydride Substances 0.000 description 2
• 229910000104 sodium hydride Inorganic materials 0.000 description 2
• RMBAVIFYHOYIFM-UHFFFAOYSA-M sodium methanethiolate Chemical compound [Na+].[S-]C RMBAVIFYHOYIFM-UHFFFAOYSA-M 0.000 description 2
• MFRIHAYPQRLWNB-UHFFFAOYSA-N sodium tert-butoxide Chemical compound [Na+].CC(C)(C)[O-] MFRIHAYPQRLWNB-UHFFFAOYSA-N 0.000 description 2
• MBBHQFDWEAGUFL-UHFFFAOYSA-N spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound O1C(N)=NCC11C(CC2)CCN2C1 MBBHQFDWEAGUFL-UHFFFAOYSA-N 0.000 description 2
• 239000003826 tablet Substances 0.000 description 2
• 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
• 150000003585 thioureas Chemical class 0.000 description 2
• VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
• PYOKUURKVVELLB-UHFFFAOYSA-N trimethyl orthoformate Chemical compound COC(OC)OC PYOKUURKVVELLB-UHFFFAOYSA-N 0.000 description 2
• 238000002604 ultrasonography Methods 0.000 description 2
• CYPYTURSJDMMMP-WVCUSYJESA-N (1e,4e)-1,5-diphenylpenta-1,4-dien-3-one;palladium Chemical compound [Pd].[Pd].C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1 CYPYTURSJDMMMP-WVCUSYJESA-N 0.000 description 1
• SSJXIUAHEKJCMH-PHDIDXHHSA-N (1r,2r)-cyclohexane-1,2-diamine Chemical compound N[C@@H]1CCCC[C@H]1N SSJXIUAHEKJCMH-PHDIDXHHSA-N 0.000 description 1
• YPWAJLGHACDYQS-UHFFFAOYSA-N (2-methoxypyrimidin-5-yl)boronic acid Chemical compound COC1=NC=C(B(O)O)C=N1 YPWAJLGHACDYQS-UHFFFAOYSA-N 0.000 description 1
• BSVHTRRLCAVQCZ-JDEXMCKMSA-N (2s)-1-[(2s)-1-[(2s)-1-[(2s)-1-[(2s)-1-[(2s)-1-[(2s)-2-[[(2s)-1-[(2s)-2-[[(2s)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-3-carboxypropanoyl]pyrrolidine-2-carbonyl]amino]propanoyl]pyrrolidine-2-carbonyl]pyrrolidine-2-carbonyl]pyrrolidine-2-carbonyl]pyrro Chemical compound C([C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(O)=O)C1=CC=C(O)C=C1 BSVHTRRLCAVQCZ-JDEXMCKMSA-N 0.000 description 1
• SDEAGACSNFSZCU-UHFFFAOYSA-N (3-chlorophenyl)boronic acid Chemical compound OB(O)C1=CC=CC(Cl)=C1 SDEAGACSNFSZCU-UHFFFAOYSA-N 0.000 description 1
• NLLGFYPSWCMUIV-UHFFFAOYSA-N (3-methoxyphenyl)boronic acid Chemical compound COC1=CC=CC(B(O)O)=C1 NLLGFYPSWCMUIV-UHFFFAOYSA-N 0.000 description 1
• VUSUESCSIUWQMT-INIZCTEOSA-N (3r)-n-(1,3-benzothiazol-2-yl)spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound C1N(CC2)CCC2[C@]21OC(NC=1SC3=CC=CC=C3N=1)=NC2 VUSUESCSIUWQMT-INIZCTEOSA-N 0.000 description 1
• YKBNMVULSUSZJK-LBPRGKRZSA-N (3r)-n-(1,3-thiazol-2-yl)spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound C([C@]1(C2CCN(CC2)C1)O1)N=C1NC1=NC=CS1 YKBNMVULSUSZJK-LBPRGKRZSA-N 0.000 description 1
• GCNACWFBHLOXPI-AWEZNQCLSA-N (3r)-n-(2-bromopyridin-4-yl)spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound C1=NC(Br)=CC(NC=2O[C@@]3(C4CCN(CC4)C3)CN=2)=C1 GCNACWFBHLOXPI-AWEZNQCLSA-N 0.000 description 1
• MDSDFKBIYXYXNF-INIZCTEOSA-N (3r)-n-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound C1N(CC2)CCC2[C@]21OC(NC=1SC=3CCCCC=3N=1)=NC2 MDSDFKBIYXYXNF-INIZCTEOSA-N 0.000 description 1
• OMNHZKWWQQBAMJ-INIZCTEOSA-N (3r)-n-(4-chloro-1,3-benzothiazol-2-yl)spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound C1N(CC2)CCC2[C@]1(O1)CN=C1NC(S1)=NC2=C1C=CC=C2Cl OMNHZKWWQQBAMJ-INIZCTEOSA-N 0.000 description 1
• LUMIIFRRDJKEKE-HNNXBMFYSA-N (3r)-n-(4-propan-2-yl-1,3-thiazol-2-yl)spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound CC(C)C1=CSC(NC=2O[C@@]3(C4CCN(CC4)C3)CN=2)=N1 LUMIIFRRDJKEKE-HNNXBMFYSA-N 0.000 description 1
• LSVLHXBLFBHBCC-INIZCTEOSA-N (3r)-n-(5-methoxy-[1,3]thiazolo[5,4-b]pyridin-2-yl)spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound C1N(CC2)CCC2[C@]1(O1)CN=C1NC1=NC2=CC=C(OC)N=C2S1 LSVLHXBLFBHBCC-INIZCTEOSA-N 0.000 description 1
• KQOOSJRLDUUAGK-AWEZNQCLSA-N (3r)-n-(6-bromopyridin-2-yl)spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound BrC1=CC=CC(NC=2O[C@@]3(C4CCN(CC4)C3)CN=2)=N1 KQOOSJRLDUUAGK-AWEZNQCLSA-N 0.000 description 1
• IYKYOSGGIVUSNM-SFHVURJKSA-N (3r)-n-(6-pyridin-3-ylpyrimidin-4-yl)spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound C([C@]1(C2CCN(CC2)C1)O1)N=C1NC(N=CN=1)=CC=1C1=CC=CN=C1 IYKYOSGGIVUSNM-SFHVURJKSA-N 0.000 description 1
• KRKCUYONLACVIN-AWEZNQCLSA-N (3r)-n-([1,3]thiazolo[4,5-b]pyrazin-2-yl)spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound C1N(CC2)CCC2[C@]21OC(NC=1SC3=NC=CN=C3N=1)=NC2 KRKCUYONLACVIN-AWEZNQCLSA-N 0.000 description 1
• WWBYXUSUDJVAED-IBGZPJMESA-N (3r)-n-[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound C1=CC(OC)=CC=C1C1=CSC(NC=2O[C@@]3(C4CCN(CC4)C3)CN=2)=N1 WWBYXUSUDJVAED-IBGZPJMESA-N 0.000 description 1
• WZQFQYUVIUGQRH-FQEVSTJZSA-N (3r)-n-[6-(3-methoxyphenyl)pyrimidin-4-yl]spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound COC1=CC=CC(C=2N=CN=C(NC=3O[C@@]4(C5CCN(CC5)C4)CN=3)C=2)=C1 WZQFQYUVIUGQRH-FQEVSTJZSA-N 0.000 description 1
• VUSUESCSIUWQMT-MRXNPFEDSA-N (3s)-n-(1,3-benzothiazol-2-yl)spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound C1N(CC2)CCC2[C@@]21OC(NC=1SC3=CC=CC=C3N=1)=NC2 VUSUESCSIUWQMT-MRXNPFEDSA-N 0.000 description 1
• MDSDFKBIYXYXNF-MRXNPFEDSA-N (3s)-n-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound C1N(CC2)CCC2[C@@]21OC(NC=1SC=3CCCCC=3N=1)=NC2 MDSDFKBIYXYXNF-MRXNPFEDSA-N 0.000 description 1
• OMNHZKWWQQBAMJ-MRXNPFEDSA-N (3s)-n-(4-chloro-1,3-benzothiazol-2-yl)spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound C1N(CC2)CCC2[C@@]1(O1)CN=C1NC(S1)=NC2=C1C=CC=C2Cl OMNHZKWWQQBAMJ-MRXNPFEDSA-N 0.000 description 1
• LUMIIFRRDJKEKE-OAHLLOKOSA-N (3s)-n-(4-propan-2-yl-1,3-thiazol-2-yl)spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound CC(C)C1=CSC(NC=2O[C@]3(C4CCN(CC4)C3)CN=2)=N1 LUMIIFRRDJKEKE-OAHLLOKOSA-N 0.000 description 1
• OOBAKOVFHQMAIS-CYBMUJFWSA-N (3s)-n-(5-chloropyrazin-2-yl)spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound C1=NC(Cl)=CN=C1NC(O1)=NC[C@@]11C(CC2)CCN2C1 OOBAKOVFHQMAIS-CYBMUJFWSA-N 0.000 description 1
• LSVLHXBLFBHBCC-MRXNPFEDSA-N (3s)-n-(5-methoxy-[1,3]thiazolo[5,4-b]pyridin-2-yl)spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound C1N(CC2)CCC2[C@@]1(O1)CN=C1NC1=NC2=CC=C(OC)N=C2S1 LSVLHXBLFBHBCC-MRXNPFEDSA-N 0.000 description 1
• WWBYXUSUDJVAED-LJQANCHMSA-N (3s)-n-[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound C1=CC(OC)=CC=C1C1=CSC(NC=2O[C@]3(C4CCN(CC4)C3)CN=2)=N1 WWBYXUSUDJVAED-LJQANCHMSA-N 0.000 description 1
• CAYQIZIAYYNFCS-UHFFFAOYSA-N (4-chlorophenyl)boronic acid Chemical compound OB(O)C1=CC=C(Cl)C=C1 CAYQIZIAYYNFCS-UHFFFAOYSA-N 0.000 description 1
• HOLROQIWWMVXRR-CQSZACIVSA-N (5R)-3-(6-bromo-[1,3]thiazolo[4,5-b]pyrazin-2-yl)spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane] Chemical compound BrC1=CN=C2C(=N1)SC(=N2)N1CO[C@]2(CN3CCC2CC3)C1 HOLROQIWWMVXRR-CQSZACIVSA-N 0.000 description 1
• 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 description 1
• UKGJZDSUJSPAJL-YPUOHESYSA-N (e)-n-[(1r)-1-[3,5-difluoro-4-(methanesulfonamido)phenyl]ethyl]-3-[2-propyl-6-(trifluoromethyl)pyridin-3-yl]prop-2-enamide Chemical compound CCCC1=NC(C(F)(F)F)=CC=C1\C=C\C(=O)N[C@H](C)C1=CC(F)=C(NS(C)(=O)=O)C(F)=C1 UKGJZDSUJSPAJL-YPUOHESYSA-N 0.000 description 1
• NHLSXQSQHXPPDQ-UHFFFAOYSA-N 1,1-bis(methylsulfanyl)-n-(5-phenylmethoxy-[1,3]thiazolo[5,4-b]pyridin-2-yl)methanimine Chemical compound N1=C2SC(N=C(SC)SC)=NC2=CC=C1OCC1=CC=CC=C1 NHLSXQSQHXPPDQ-UHFFFAOYSA-N 0.000 description 1
• KZGYCTBSZHPCAQ-UHFFFAOYSA-N 1,1-bis(methylsulfanyl)-n-([1,3]thiazolo[5,4-b]pyridin-2-yl)methanimine Chemical compound C1=CN=C2SC(N=C(SC)SC)=NC2=C1 KZGYCTBSZHPCAQ-UHFFFAOYSA-N 0.000 description 1
• GRPQPFMTBPFPPY-UHFFFAOYSA-N 1,1-bis(methylsulfanyl)-n-pyrimidin-2-ylmethanimine Chemical compound CSC(SC)=NC1=NC=CC=N1 GRPQPFMTBPFPPY-UHFFFAOYSA-N 0.000 description 1
• CSNIZNHTOVFARY-UHFFFAOYSA-N 1,2-benzothiazole Chemical group C1=CC=C2C=NSC2=C1 CSNIZNHTOVFARY-UHFFFAOYSA-N 0.000 description 1
• KTZQTRPPVKQPFO-UHFFFAOYSA-N 1,2-benzoxazole Chemical group C1=CC=C2C=NOC2=C1 KTZQTRPPVKQPFO-UHFFFAOYSA-N 0.000 description 1
• BCMCBBGGLRIHSE-UHFFFAOYSA-N 1,3-benzoxazole Chemical group C1=CC=C2OC=NC2=C1 BCMCBBGGLRIHSE-UHFFFAOYSA-N 0.000 description 1
• RAIPHJJURHTUIC-UHFFFAOYSA-N 1,3-thiazol-2-amine Chemical compound NC1=NC=CS1 RAIPHJJURHTUIC-UHFFFAOYSA-N 0.000 description 1
• ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 1
• ZKMZPXWMMSBLNO-UHFFFAOYSA-N 1-azabicyclo[2.2.2]octan-3-one Chemical compound C1CC2C(=O)CN1CC2 ZKMZPXWMMSBLNO-UHFFFAOYSA-N 0.000 description 1
• IWUXYDCAXVQVRL-UHFFFAOYSA-N 1-azabicyclo[2.2.2]octan-3-ylmethanamine;dihydrochloride Chemical compound Cl.Cl.C1CC2C(CN)CN1CC2 IWUXYDCAXVQVRL-UHFFFAOYSA-N 0.000 description 1
• MNBAABZKRCNMAP-UHFFFAOYSA-N 1-azabicyclo[2.2.2]octane;4,5-dihydro-1,3-oxazole Chemical class C1CN=CO1.C1CC2CCN1CC2 MNBAABZKRCNMAP-UHFFFAOYSA-N 0.000 description 1
• PJUPKRYGDFTMTM-UHFFFAOYSA-N 1-hydroxybenzotriazole;hydrate Chemical compound O.C1=CC=C2N(O)N=NC2=C1 PJUPKRYGDFTMTM-UHFFFAOYSA-N 0.000 description 1
• NCSGPOWDKZUREZ-UHFFFAOYSA-N 1-methoxyquinolin-2-one Chemical compound C1=CC=C2C=CC(=O)N(OC)C2=C1 NCSGPOWDKZUREZ-UHFFFAOYSA-N 0.000 description 1
• XDFZKQJLNGNJAN-UHFFFAOYSA-N 1-methylbenzimidazol-2-amine Chemical compound C1=CC=C2N(C)C(N)=NC2=C1 XDFZKQJLNGNJAN-UHFFFAOYSA-N 0.000 description 1
• HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical group C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 description 1
• BAXOFTOLAUCFNW-UHFFFAOYSA-N 1H-indazole Chemical group C1=CC=C2C=NNC2=C1 BAXOFTOLAUCFNW-UHFFFAOYSA-N 0.000 description 1
• VYDQUABHDFWIIX-UHFFFAOYSA-N 2,2-difluoro-2-fluorosulfonylacetic acid Chemical compound OC(=O)C(F)(F)S(F)(=O)=O VYDQUABHDFWIIX-UHFFFAOYSA-N 0.000 description 1
• ALUQMCBDQKDRAK-UHFFFAOYSA-N 2,3,3a,4-tetrahydro-1,3-benzothiazole Chemical group C1C=CC=C2SCNC21 ALUQMCBDQKDRAK-UHFFFAOYSA-N 0.000 description 1
• RINHVELYMZLXIW-UHFFFAOYSA-N 2,4-dichloropyrimidin-5-amine Chemical compound NC1=CN=C(Cl)N=C1Cl RINHVELYMZLXIW-UHFFFAOYSA-N 0.000 description 1
• LJFDXXUKKMEQKE-UHFFFAOYSA-N 2,4-difluorobenzonitrile Chemical compound FC1=CC=C(C#N)C(F)=C1 LJFDXXUKKMEQKE-UHFFFAOYSA-N 0.000 description 1
• IDQNBVFPZMCDDN-UHFFFAOYSA-N 2-Amino-4,6-dimethylpyrimidine Chemical compound CC1=CC(C)=NC(N)=N1 IDQNBVFPZMCDDN-UHFFFAOYSA-N 0.000 description 1
• IMSODMZESSGVBE-UHFFFAOYSA-N 2-Oxazoline Chemical compound C1CN=CO1 IMSODMZESSGVBE-UHFFFAOYSA-N 0.000 description 1
• HMAATCOHUYHORT-UHFFFAOYSA-N 2-[(2-methylpropan-2-yl)oxycarbonylamino]-1,3-benzothiazole-6-carboxylic acid Chemical compound C1=C(C(O)=O)C=C2SC(NC(=O)OC(C)(C)C)=NC2=C1 HMAATCOHUYHORT-UHFFFAOYSA-N 0.000 description 1
• JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
• UDLFPPHYXDHXCU-INIZCTEOSA-N 2-[[(3r)-spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-yl]amino]-1,3-benzothiazol-6-ol Chemical compound C1N(CC2)CCC2[C@]1(O1)CN=C1NC1=NC2=CC=C(O)C=C2S1 UDLFPPHYXDHXCU-INIZCTEOSA-N 0.000 description 1
• UDLFPPHYXDHXCU-MRXNPFEDSA-N 2-[[(3s)-spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-yl]amino]-1,3-benzothiazol-6-ol Chemical compound C1N(CC2)CCC2[C@@]1(O1)CN=C1NC1=NC2=CC=C(O)C=C2S1 UDLFPPHYXDHXCU-MRXNPFEDSA-N 0.000 description 1
• YJOBZEMOBFJWDV-UHFFFAOYSA-N 2-[bis(methylsulfanyl)methylideneamino]-n,n-dimethyl-[1,3]thiazolo[5,4-d]pyrimidin-5-amine Chemical compound N1=C(N(C)C)N=C2SC(N=C(SC)SC)=NC2=C1 YJOBZEMOBFJWDV-UHFFFAOYSA-N 0.000 description 1
• JWYUFVNJZUSCSM-UHFFFAOYSA-N 2-aminobenzimidazole Chemical compound C1=CC=C2NC(N)=NC2=C1 JWYUFVNJZUSCSM-UHFFFAOYSA-N 0.000 description 1
• UHGULLIUJBCTEF-UHFFFAOYSA-N 2-aminobenzothiazole Chemical compound C1=CC=C2SC(N)=NC2=C1 UHGULLIUJBCTEF-UHFFFAOYSA-N 0.000 description 1
• ICSNLGPSRYBMBD-UHFFFAOYSA-N 2-aminopyridine Chemical compound NC1=CC=CC=N1 ICSNLGPSRYBMBD-UHFFFAOYSA-N 0.000 description 1
• GNTGEMWEXKBWBX-UHFFFAOYSA-N 2-bromopyridin-4-amine Chemical compound NC1=CC=NC(Br)=C1 GNTGEMWEXKBWBX-UHFFFAOYSA-N 0.000 description 1
• AOZNIFQUCUSYLD-UHFFFAOYSA-N 2-chloro-4-propan-2-ylpyrimidine Chemical compound CC(C)C1=CC=NC(Cl)=N1 AOZNIFQUCUSYLD-UHFFFAOYSA-N 0.000 description 1
• MDDZKKIHTFOAEF-UHFFFAOYSA-N 2-chloro-6-methylquinoxaline Chemical compound N1=C(Cl)C=NC2=CC(C)=CC=C21 MDDZKKIHTFOAEF-UHFFFAOYSA-N 0.000 description 1
• WJDJKCAURKUNNC-UHFFFAOYSA-N 2-chloro-7-methoxyquinoxaline Chemical compound N1=CC(Cl)=NC2=CC(OC)=CC=C21 WJDJKCAURKUNNC-UHFFFAOYSA-N 0.000 description 1
• XLTMISOVULFCFD-UHFFFAOYSA-N 2-chloro-7-methylquinoxaline Chemical compound N1=CC(Cl)=NC2=CC(C)=CC=C21 XLTMISOVULFCFD-UHFFFAOYSA-N 0.000 description 1
• MJJRDTKNLLMJDJ-UHFFFAOYSA-N 2-methoxy-1,3-thiazole Chemical compound COC1=NC=CS1 MJJRDTKNLLMJDJ-UHFFFAOYSA-N 0.000 description 1
• OCWBGKZFOYMCCN-UHFFFAOYSA-N 3,5-dichloropyridin-2-amine Chemical compound NC1=NC=C(Cl)C=C1Cl OCWBGKZFOYMCCN-UHFFFAOYSA-N 0.000 description 1
• XYYXDARQOHWBPO-UHFFFAOYSA-N 3,5-dimethyl-1h-1,2,4-triazole Chemical compound CC1=NNC(C)=N1 XYYXDARQOHWBPO-UHFFFAOYSA-N 0.000 description 1
• IRVIOWMNBBNPNC-UHFFFAOYSA-N 3-(1,3-thiazol-2-yl)spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane] Chemical compound S1C(=NC=C1)N1COC2(CN3CCC2CC3)C1 IRVIOWMNBBNPNC-UHFFFAOYSA-N 0.000 description 1
• MESWZJXURVTILO-UHFFFAOYSA-N 3-(5-methoxy-[1,3]thiazolo[5,4-b]pyridin-2-yl)spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane] Chemical compound COC1=CC=C2C(=N1)SC(=N2)N1COC2(CN3CCC2CC3)C1 MESWZJXURVTILO-UHFFFAOYSA-N 0.000 description 1
• CUYKNJBYIJFRCU-UHFFFAOYSA-N 3-aminopyridine Chemical compound NC1=CC=CN=C1 CUYKNJBYIJFRCU-UHFFFAOYSA-N 0.000 description 1
• VMSZFBSYWXMXRF-UHFFFAOYSA-N 3-isothiocyanatopyridine Chemical compound S=C=NC1=CC=CN=C1 VMSZFBSYWXMXRF-UHFFFAOYSA-N 0.000 description 1
• LGNNZKURGCOEJY-UHFFFAOYSA-N 3-methyl-1,2,4-oxadiazol-5-amine Chemical compound CC1=NOC(N)=N1 LGNNZKURGCOEJY-UHFFFAOYSA-N 0.000 description 1
• DJKUIGPCSNRFRK-UHFFFAOYSA-N 3-methyl-1,2,4-thiadiazol-5-amine Chemical compound CC1=NSC(N)=N1 DJKUIGPCSNRFRK-UHFFFAOYSA-N 0.000 description 1
• SMWAOXCEPHEGFV-UHFFFAOYSA-N 4,5,6,7-tetrahydro-1,3-benzothiazol-2-amine Chemical compound C1CCCC2=C1N=C(N)S2 SMWAOXCEPHEGFV-UHFFFAOYSA-N 0.000 description 1
• CRRAQLWJVYODCL-UHFFFAOYSA-N 4,5-dichloropyridin-2-amine Chemical compound NC1=CC(Cl)=C(Cl)C=N1 CRRAQLWJVYODCL-UHFFFAOYSA-N 0.000 description 1
• WUTXFLYFZOMYSF-UHFFFAOYSA-N 4-(4-methoxyphenyl)-5-methyl-1,3-thiazol-2-amine Chemical compound C1=CC(OC)=CC=C1C1=C(C)SC(N)=N1 WUTXFLYFZOMYSF-UHFFFAOYSA-N 0.000 description 1
• OERIHGQAGTVWPN-UHFFFAOYSA-N 4-(difluoromethoxy)-2-fluorobenzonitrile Chemical compound FC(F)OC1=CC=C(C#N)C(F)=C1 OERIHGQAGTVWPN-UHFFFAOYSA-N 0.000 description 1
• NDEZTSHWEPQVBX-UHFFFAOYSA-N 4-(difluoromethoxy)aniline Chemical compound NC1=CC=C(OC(F)F)C=C1 NDEZTSHWEPQVBX-UHFFFAOYSA-N 0.000 description 1
• XYWIPYBIIRTJMM-IBGZPJMESA-N 4-[[(2S)-2-[4-[5-chloro-2-[4-(trifluoromethyl)triazol-1-yl]phenyl]-5-methoxy-2-oxopyridin-1-yl]butanoyl]amino]-2-fluorobenzamide Chemical compound CC[C@H](N1C=C(OC)C(=CC1=O)C1=C(C=CC(Cl)=C1)N1C=C(N=N1)C(F)(F)F)C(=O)NC1=CC(F)=C(C=C1)C(N)=O XYWIPYBIIRTJMM-IBGZPJMESA-N 0.000 description 1
• OEQQFQXMCPMEIH-UHFFFAOYSA-N 4-chloro-1,3-benzothiazol-2-amine Chemical compound C1=CC=C2SC(N)=NC2=C1Cl OEQQFQXMCPMEIH-UHFFFAOYSA-N 0.000 description 1
• RRMVDLLCVGZDMH-UHFFFAOYSA-N 4-chloro-5,6-dimethylpyrimidin-2-amine Chemical compound CC1=NC(N)=NC(Cl)=C1C RRMVDLLCVGZDMH-UHFFFAOYSA-N 0.000 description 1
• OPFFYLJLHPZSEO-UHFFFAOYSA-N 4-chlorofuro[3,2-c]pyridine Chemical compound ClC1=NC=CC2=C1C=CO2 OPFFYLJLHPZSEO-UHFFFAOYSA-N 0.000 description 1
• 229960000549 4-dimethylaminophenol Drugs 0.000 description 1
• AGAHETWGCFCMDK-UHFFFAOYSA-N 4-methoxybenzene-1,2-diamine Chemical compound COC1=CC=C(N)C(N)=C1 AGAHETWGCFCMDK-UHFFFAOYSA-N 0.000 description 1
• GRIATXVEXOFBGO-UHFFFAOYSA-N 4-methyl-1,3-benzothiazol-2-amine Chemical compound CC1=CC=CC2=C1N=C(N)S2 GRIATXVEXOFBGO-UHFFFAOYSA-N 0.000 description 1
• SJISCEAZUHNOMD-UHFFFAOYSA-N 4-phenylcyclohexan-1-amine Chemical compound C1CC(N)CCC1C1=CC=CC=C1 SJISCEAZUHNOMD-UHFFFAOYSA-N 0.000 description 1
• LGPVXXJBWWYOSL-UHFFFAOYSA-N 4-propan-2-yl-1,3-thiazol-2-amine Chemical compound CC(C)C1=CSC(N)=N1 LGPVXXJBWWYOSL-UHFFFAOYSA-N 0.000 description 1
• MLNFMFAMNBGAQT-UHFFFAOYSA-N 4-propan-2-yloxyaniline Chemical compound CC(C)OC1=CC=C(N)C=C1 MLNFMFAMNBGAQT-UHFFFAOYSA-N 0.000 description 1
• LQHQKYWYKPLKCH-UHFFFAOYSA-N 4-pyridin-3-ylpyrimidin-2-amine Chemical compound NC1=NC=CC(C=2C=NC=CC=2)=N1 LQHQKYWYKPLKCH-UHFFFAOYSA-N 0.000 description 1
• PWRHKLKFADDKHS-UHFFFAOYSA-N 5,6-diamino-1h-pyrimidin-4-one Chemical compound NC=1NC=NC(=O)C=1N PWRHKLKFADDKHS-UHFFFAOYSA-N 0.000 description 1
• MVRGZAICFHFZIJ-UHFFFAOYSA-N 5-(4-methoxyphenyl)-1,3-thiazol-2-amine Chemical compound C1=CC(OC)=CC=C1C1=CN=C(N)S1 MVRGZAICFHFZIJ-UHFFFAOYSA-N 0.000 description 1
• MDQXGHBCDCOOSM-UHFFFAOYSA-N 5-bromopyridin-3-amine Chemical compound NC1=CN=CC(Br)=C1 MDQXGHBCDCOOSM-UHFFFAOYSA-N 0.000 description 1
• DGRCJSWXMGENMG-UHFFFAOYSA-N 5-chloro-4-methylpyridin-2-amine Chemical compound CC1=CC(N)=NC=C1Cl DGRCJSWXMGENMG-UHFFFAOYSA-N 0.000 description 1
• WCCLUBJCLSIZOC-UHFFFAOYSA-N 5-chloro-[1,3]thiazolo[5,4-b]pyridin-2-amine Chemical compound C1=C(Cl)N=C2SC(N)=NC2=C1 WCCLUBJCLSIZOC-UHFFFAOYSA-N 0.000 description 1
• XHSTYRIUVMKGDX-UHFFFAOYSA-N 5-ethyl-1,3,4-oxadiazol-2-amine Chemical compound CCC1=NN=C(N)O1 XHSTYRIUVMKGDX-UHFFFAOYSA-N 0.000 description 1
• ASOREQWGEDVBSR-UHFFFAOYSA-N 5-methoxy-1,3-thiazole Chemical compound COC1=CN=CS1 ASOREQWGEDVBSR-UHFFFAOYSA-N 0.000 description 1
• JGNUNWXQPBDFMP-UHFFFAOYSA-N 5-methoxy-2,4-dimethyl-1,3-thiazole Chemical compound COC=1SC(C)=NC=1C JGNUNWXQPBDFMP-UHFFFAOYSA-N 0.000 description 1
• XJKJHILCYUUVSJ-UHFFFAOYSA-N 5-methoxypyridin-2-amine Chemical compound COC1=CC=C(N)N=C1 XJKJHILCYUUVSJ-UHFFFAOYSA-N 0.000 description 1
• XPXWYVCQCNFIIJ-UHFFFAOYSA-N 5-methyl-1,3,4-oxadiazol-2-amine Chemical compound CC1=NN=C(N)O1 XPXWYVCQCNFIIJ-UHFFFAOYSA-N 0.000 description 1
• XKWSQIMYNVLGBO-UHFFFAOYSA-N 5-nitro-1h-pyridin-2-one Chemical compound OC1=CC=C([N+]([O-])=O)C=N1 XKWSQIMYNVLGBO-UHFFFAOYSA-N 0.000 description 1
• LSLUWQIENURREM-UHFFFAOYSA-N 5-phenyl-1,3-thiazol-2-amine Chemical compound S1C(N)=NC=C1C1=CC=CC=C1 LSLUWQIENURREM-UHFFFAOYSA-N 0.000 description 1
• CYPQOKFUBWWAET-UHFFFAOYSA-N 5-pyridin-3-ylpyridin-2-amine Chemical compound C1=NC(N)=CC=C1C1=CC=CN=C1 CYPQOKFUBWWAET-UHFFFAOYSA-N 0.000 description 1
• HTWQXUINJKVXIO-UHFFFAOYSA-N 6-(4-chlorophenyl)pyrimidin-4-amine Chemical compound C1=NC(N)=CC(C=2C=CC(Cl)=CC=2)=N1 HTWQXUINJKVXIO-UHFFFAOYSA-N 0.000 description 1
• JHQJTIIYVDDSEN-UHFFFAOYSA-N 6-[tert-butyl(dimethyl)silyl]oxy-1,3-benzothiazol-2-amine Chemical compound CC(C)(C)[Si](C)(C)OC1=CC=C2N=C(N)SC2=C1 JHQJTIIYVDDSEN-UHFFFAOYSA-N 0.000 description 1
• ZFXMWBGQRGABCI-UHFFFAOYSA-N 6-amino-2,4-dimethylpyridine-3-carbonitrile Chemical compound CC1=CC(N)=NC(C)=C1C#N ZFXMWBGQRGABCI-UHFFFAOYSA-N 0.000 description 1
• OZAIJUZOQOBQDW-UHFFFAOYSA-N 6-amino-2-methylpyridine-3-carbonitrile Chemical compound CC1=NC(N)=CC=C1C#N OZAIJUZOQOBQDW-UHFFFAOYSA-N 0.000 description 1
• XYAFECHDSIQGHU-UHFFFAOYSA-N 6-bromo-[1,3]thiazolo[4,5-b]pyrazin-2-amine Chemical compound C1=C(Br)N=C2SC(N)=NC2=N1 XYAFECHDSIQGHU-UHFFFAOYSA-N 0.000 description 1
• VMNXKIDUTPOHPO-UHFFFAOYSA-N 6-chloro-1,3-benzothiazol-2-amine Chemical compound C1=C(Cl)C=C2SC(N)=NC2=C1 VMNXKIDUTPOHPO-UHFFFAOYSA-N 0.000 description 1
• KOYJWFGMEBETBU-UHFFFAOYSA-N 6-ethoxy-1,3-benzothiazol-2-amine Chemical compound CCOC1=CC=C2N=C(N)SC2=C1 KOYJWFGMEBETBU-UHFFFAOYSA-N 0.000 description 1
• KZHGPDSVHSDCMX-UHFFFAOYSA-N 6-methoxy-1,3-benzothiazol-2-amine Chemical compound COC1=CC=C2N=C(N)SC2=C1 KZHGPDSVHSDCMX-UHFFFAOYSA-N 0.000 description 1
• SYEUUDPGKMMKRU-UHFFFAOYSA-N 6-methoxy-1h-quinoxalin-2-one Chemical compound N1C(=O)C=NC2=CC(OC)=CC=C21 SYEUUDPGKMMKRU-UHFFFAOYSA-N 0.000 description 1
• UUVDJIWRSIJEBS-UHFFFAOYSA-N 6-methoxypyridin-3-amine Chemical compound COC1=CC=C(N)C=N1 UUVDJIWRSIJEBS-UHFFFAOYSA-N 0.000 description 1
• VELRBZDRGTVGGT-UHFFFAOYSA-N 6-methoxypyrimidin-4-amine Chemical compound COC1=CC(N)=NC=N1 VELRBZDRGTVGGT-UHFFFAOYSA-N 0.000 description 1
• IADRCPCBGGCJKR-UHFFFAOYSA-N 6-methoxyquinolin-2-amine Chemical compound N1=C(N)C=CC2=CC(OC)=CC=C21 IADRCPCBGGCJKR-UHFFFAOYSA-N 0.000 description 1
• DZWTXWPRWRLHIL-UHFFFAOYSA-N 6-methyl-1,3-benzothiazol-2-amine Chemical compound CC1=CC=C2N=C(N)SC2=C1 DZWTXWPRWRLHIL-UHFFFAOYSA-N 0.000 description 1
• CDCFXBSOKSIQPU-UHFFFAOYSA-N 6-phenylmethoxypyridin-3-amine Chemical compound N1=CC(N)=CC=C1OCC1=CC=CC=C1 CDCFXBSOKSIQPU-UHFFFAOYSA-N 0.000 description 1
• GSWUMGAQTSRPQB-UHFFFAOYSA-N 7-methoxyquinolin-2-amine Chemical compound C1=CC(N)=NC2=CC(OC)=CC=C21 GSWUMGAQTSRPQB-UHFFFAOYSA-N 0.000 description 1
• IVHJSNNMKJWPFW-UHFFFAOYSA-N 7-methoxyquinoline Chemical compound C1=CC=NC2=CC(OC)=CC=C21 IVHJSNNMKJWPFW-UHFFFAOYSA-N 0.000 description 1
• LZRAIJXDIVIZGX-UHFFFAOYSA-N 7-methylquinoxalin-2-amine Chemical compound N1=CC(N)=NC2=CC(C)=CC=C21 LZRAIJXDIVIZGX-UHFFFAOYSA-N 0.000 description 1
• ODGPJSALOCAXRG-UHFFFAOYSA-N 7-methylquinoxalin-2-amine;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.N1=CC(N)=NC2=CC(C)=CC=C21 ODGPJSALOCAXRG-UHFFFAOYSA-N 0.000 description 1
• 229930000680 A04AD01 - Scopolamine Natural products 0.000 description 1
• 101710195183 Alpha-bungarotoxin Proteins 0.000 description 1
• QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
• USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
• 239000005695 Ammonium acetate Substances 0.000 description 1
• 208000007415 Anhedonia Diseases 0.000 description 1
• 229930003347 Atropine Natural products 0.000 description 1
• BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
• CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
• 101100165177 Caenorhabditis elegans bath-15 gene Proteins 0.000 description 1
• OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
• 108090000312 Calcium Channels Proteins 0.000 description 1
• 102000003922 Calcium Channels Human genes 0.000 description 1
• OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
• 108091005462 Cation channels Proteins 0.000 description 1
• 102000009660 Cholinergic Receptors Human genes 0.000 description 1
• 108010009685 Cholinergic Receptors Proteins 0.000 description 1
• KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
• 208000028698 Cognitive impairment Diseases 0.000 description 1
• 206010010144 Completed suicide Diseases 0.000 description 1
• 229910021595 Copper(I) iodide Inorganic materials 0.000 description 1
• AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 description 1
• 206010012239 Delusion Diseases 0.000 description 1
• 206010012289 Dementia Diseases 0.000 description 1
• FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
• 238000002965 ELISA Methods 0.000 description 1
• VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 1
• 239000007995 HEPES buffer Substances 0.000 description 1
• 229910004373 HOAc Inorganic materials 0.000 description 1
• 208000004547 Hallucinations Diseases 0.000 description 1
• 208000005176 Hepatitis C Diseases 0.000 description 1
• CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
• AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 1
• RKUNBYITZUJHSG-UHFFFAOYSA-N Hyosciamin-hydrochlorid Natural products CN1C(C2)CCC1CC2OC(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-UHFFFAOYSA-N 0.000 description 1
• STECJAGHUSJQJN-GAUPFVANSA-N Hyoscine Natural products C1([C@H](CO)C(=O)OC2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-GAUPFVANSA-N 0.000 description 1
• 206010061218 Inflammation Diseases 0.000 description 1
• 239000007836 KH2PO4 Substances 0.000 description 1
• JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
• WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
• KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
• 239000004472 Lysine Substances 0.000 description 1
• FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
• 208000026139 Memory disease Diseases 0.000 description 1
• 241001465754 Metazoa Species 0.000 description 1
• AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
• BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 1
• 241000699670 Mus sp. Species 0.000 description 1
• STECJAGHUSJQJN-UHFFFAOYSA-N N-Methyl-scopolamin Natural products C1C(C2C3O2)N(C)C3CC1OC(=O)C(CO)C1=CC=CC=C1 STECJAGHUSJQJN-UHFFFAOYSA-N 0.000 description 1
• FEYNFHSRETUBEM-UHFFFAOYSA-N N-[3-(1,1-difluoroethyl)phenyl]-1-(4-methoxyphenyl)-3-methyl-5-oxo-4H-pyrazole-4-carboxamide Chemical compound COc1ccc(cc1)N1N=C(C)C(C(=O)Nc2cccc(c2)C(C)(F)F)C1=O FEYNFHSRETUBEM-UHFFFAOYSA-N 0.000 description 1
• MBBZMMPHUWSWHV-BDVNFPICSA-N N-methylglucamine Chemical compound CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO MBBZMMPHUWSWHV-BDVNFPICSA-N 0.000 description 1
• PWUBEALFLKCYFE-GOSISDBHSA-N N1=CC(=CC=C1)C=1N=CC(=NC1)N1CO[C@]2(CN3CCC2CC3)C1 Chemical compound N1=CC(=CC=C1)C=1N=CC(=NC1)N1CO[C@]2(CN3CCC2CC3)C1 PWUBEALFLKCYFE-GOSISDBHSA-N 0.000 description 1
• VLQGDKKHHCKIOJ-UHFFFAOYSA-N NNOS Chemical compound NNOS VLQGDKKHHCKIOJ-UHFFFAOYSA-N 0.000 description 1
• 229910002651 NO3 Inorganic materials 0.000 description 1
• IQSWKDCJBWGNPD-UHFFFAOYSA-N NSBr Chemical compound NSBr IQSWKDCJBWGNPD-UHFFFAOYSA-N 0.000 description 1
• 101100030361 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) pph-3 gene Proteins 0.000 description 1
• 102000004108 Neurotransmitter Receptors Human genes 0.000 description 1
• 108090000590 Neurotransmitter Receptors Proteins 0.000 description 1
• NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
• QACBVVUGNLOUEF-MRXNPFEDSA-N O1C=CC=2C(=NC=CC21)N2CO[C@]1(CN3CCC1CC3)C2 Chemical compound O1C=CC=2C(=NC=CC21)N2CO[C@]1(CN3CCC1CC3)C2 QACBVVUGNLOUEF-MRXNPFEDSA-N 0.000 description 1
• 240000007817 Olea europaea Species 0.000 description 1
• 229910019142 PO4 Inorganic materials 0.000 description 1
• 206010033864 Paranoia Diseases 0.000 description 1
• 208000027099 Paranoid disease Diseases 0.000 description 1
• 108010077495 Peptide oostatic hormone Proteins 0.000 description 1
• PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Chemical group C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 description 1
• ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
• XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
• 229940124158 Protease/peptidase inhibitor Drugs 0.000 description 1
• 102000007568 Proto-Oncogene Proteins c-fos Human genes 0.000 description 1
• 108010071563 Proto-Oncogene Proteins c-fos Proteins 0.000 description 1
• WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical group C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 description 1
• CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical group C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
• 241000700157 Rattus norvegicus Species 0.000 description 1
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
• QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
• 241000718541 Tetragastris balsamifera Species 0.000 description 1
• FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical group C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 1
• RHQDFWAXVIIEBN-UHFFFAOYSA-N Trifluoroethanol Chemical compound OCC(F)(F)F RHQDFWAXVIIEBN-UHFFFAOYSA-N 0.000 description 1
• HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
• VTIVYUBSVCXRPI-UHFFFAOYSA-N [1,2]thiazolo[5,4-b]pyridine Chemical group C1=CC=C2C=NSC2=N1 VTIVYUBSVCXRPI-UHFFFAOYSA-N 0.000 description 1
• OGWPHTRWLWDCOC-UHFFFAOYSA-N [1,3]thiazolo[5,4-b]pyridin-2-amine Chemical compound C1=CN=C2SC(N)=NC2=C1 OGWPHTRWLWDCOC-UHFFFAOYSA-N 0.000 description 1
• WFIHKLWVLPBMIQ-UHFFFAOYSA-N [1,3]thiazolo[5,4-b]pyridine Chemical group C1=CN=C2SC=NC2=C1 WFIHKLWVLPBMIQ-UHFFFAOYSA-N 0.000 description 1
• KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
• XPOLVIIHTDKJRY-UHFFFAOYSA-N acetic acid;methanimidamide Chemical compound NC=N.CC(O)=O XPOLVIIHTDKJRY-UHFFFAOYSA-N 0.000 description 1
• QOMNQGZXFYNBNG-UHFFFAOYSA-N acetyloxymethyl 2-[2-[2-[5-[3-(acetyloxymethoxy)-2,7-difluoro-6-oxoxanthen-9-yl]-2-[bis[2-(acetyloxymethoxy)-2-oxoethyl]amino]phenoxy]ethoxy]-n-[2-(acetyloxymethoxy)-2-oxoethyl]-4-methylanilino]acetate Chemical compound CC(=O)OCOC(=O)CN(CC(=O)OCOC(C)=O)C1=CC=C(C)C=C1OCCOC1=CC(C2=C3C=C(F)C(=O)C=C3OC3=CC(OCOC(C)=O)=C(F)C=C32)=CC=C1N(CC(=O)OCOC(C)=O)CC(=O)OCOC(C)=O QOMNQGZXFYNBNG-UHFFFAOYSA-N 0.000 description 1
• 238000010306 acid treatment Methods 0.000 description 1
• 230000002378 acidificating effect Effects 0.000 description 1
• 230000009471 action Effects 0.000 description 1
• 239000004480 active ingredient Substances 0.000 description 1
• 238000013019 agitation Methods 0.000 description 1
• 150000001298 alcohols Chemical class 0.000 description 1
• 125000003342 alkenyl group Chemical group 0.000 description 1
• 125000000304 alkynyl group Chemical group 0.000 description 1
• 102000047725 alpha7 Nicotinic Acetylcholine Receptor Human genes 0.000 description 1
• 108700006085 alpha7 Nicotinic Acetylcholine Receptor Proteins 0.000 description 1
• 229910052782 aluminium Inorganic materials 0.000 description 1
• XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
• 150000001408 amides Chemical class 0.000 description 1
• 125000003277 amino group Chemical group 0.000 description 1
• 229910021529 ammonia Inorganic materials 0.000 description 1
• 229940043376 ammonium acetate Drugs 0.000 description 1
• 235000019257 ammonium acetate Nutrition 0.000 description 1
• 238000004458 analytical method Methods 0.000 description 1
• 125000000129 anionic group Chemical group 0.000 description 1
• 230000000949 anxiolytic effect Effects 0.000 description 1
• 229910052786 argon Inorganic materials 0.000 description 1
• 150000004982 aromatic amines Chemical class 0.000 description 1
• 125000003118 aryl group Chemical group 0.000 description 1
• 239000012131 assay buffer Substances 0.000 description 1
• 239000012298 atmosphere Substances 0.000 description 1
• RKUNBYITZUJHSG-SPUOUPEWSA-N atropine Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)N2C)C(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-SPUOUPEWSA-N 0.000 description 1
• 229960000396 atropine Drugs 0.000 description 1
• 239000003693 atypical antipsychotic agent Substances 0.000 description 1
• 229940127236 atypical antipsychotics Drugs 0.000 description 1
• 230000006736 behavioral deficit Effects 0.000 description 1
• 230000003542 behavioural effect Effects 0.000 description 1
• JUHORIMYRDESRB-UHFFFAOYSA-N benzathine Chemical compound C=1C=CC=CC=1CNCCNCC1=CC=CC=C1 JUHORIMYRDESRB-UHFFFAOYSA-N 0.000 description 1
• SRSXLGNVWSONIS-UHFFFAOYSA-M benzenesulfonate Chemical compound [O-]S(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-M 0.000 description 1
• 125000005605 benzo group Chemical group 0.000 description 1
• 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 1
• MUALRAIOVNYAIW-UHFFFAOYSA-N binap Chemical compound C1=CC=CC=C1P(C=1C(=C2C=CC=CC2=CC=1)C=1C2=CC=CC=C2C=CC=1P(C=1C=CC=CC=1)C=1C=CC=CC=1)C1=CC=CC=C1 MUALRAIOVNYAIW-UHFFFAOYSA-N 0.000 description 1
• 239000011230 binding agent Substances 0.000 description 1
• 229910052797 bismuth Inorganic materials 0.000 description 1
• JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 description 1
• 230000037396 body weight Effects 0.000 description 1
• 210000005013 brain tissue Anatomy 0.000 description 1
• 229910052791 calcium Inorganic materials 0.000 description 1
• 239000002775 capsule Substances 0.000 description 1
• DKVNPHBNOWQYFE-UHFFFAOYSA-N carbamodithioic acid Chemical class NC(S)=S DKVNPHBNOWQYFE-UHFFFAOYSA-N 0.000 description 1
• 150000001718 carbodiimides Chemical class 0.000 description 1
• QGJOPFRUJISHPQ-NJFSPNSNSA-N carbon disulfide-14c Chemical compound S=[14C]=S QGJOPFRUJISHPQ-NJFSPNSNSA-N 0.000 description 1
• 239000003054 catalyst Substances 0.000 description 1
• 238000009903 catalytic hydrogenation reaction Methods 0.000 description 1
• 125000002091 cationic group Chemical group 0.000 description 1
• 150000001768 cations Chemical class 0.000 description 1
• 238000004113 cell culture Methods 0.000 description 1
• 230000008859 change Effects 0.000 description 1
• DGLFSNZWRYADFC-UHFFFAOYSA-N chembl2334586 Chemical compound C1CCC2=CN=C(N)N=C2C2=C1NC1=CC=C(C#CC(C)(O)C)C=C12 DGLFSNZWRYADFC-UHFFFAOYSA-N 0.000 description 1
• 238000002038 chemiluminescence detection Methods 0.000 description 1
• 150000001805 chlorine compounds Chemical class 0.000 description 1
• NDTCXABJQNJPCF-UHFFFAOYSA-N chlorocyclopentane Chemical compound ClC1CCCC1 NDTCXABJQNJPCF-UHFFFAOYSA-N 0.000 description 1
• 239000002036 chloroform fraction Substances 0.000 description 1
• WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 1
• OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
• 229960001231 choline Drugs 0.000 description 1
• 230000007278 cognition impairment Effects 0.000 description 1
• 230000001149 cognitive effect Effects 0.000 description 1
• 239000012230 colorless oil Substances 0.000 description 1
• 239000012141 concentrate Substances 0.000 description 1
• 235000008504 concentrate Nutrition 0.000 description 1
• 239000000470 constituent Substances 0.000 description 1
• 238000001816 cooling Methods 0.000 description 1
• LSXDOTMGLUJQCM-UHFFFAOYSA-M copper(i) iodide Chemical compound I[Cu] LSXDOTMGLUJQCM-UHFFFAOYSA-M 0.000 description 1
• 239000006071 cream Substances 0.000 description 1
• 238000011461 current therapy Methods 0.000 description 1
• ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 1
• XCIXKGXIYUWCLL-UHFFFAOYSA-N cyclopentanol Chemical compound OC1CCCC1 XCIXKGXIYUWCLL-UHFFFAOYSA-N 0.000 description 1
• 210000000805 cytoplasm Anatomy 0.000 description 1
• 230000034994 death Effects 0.000 description 1
• 230000007812 deficiency Effects 0.000 description 1
• 230000006735 deficit Effects 0.000 description 1
• 231100000868 delusion Toxicity 0.000 description 1
• 239000007933 dermal patch Substances 0.000 description 1
• 238000011161 development Methods 0.000 description 1
• 238000003745 diagnosis Methods 0.000 description 1
• WGLUMOCWFMKWIL-UHFFFAOYSA-N dichloromethane;methanol Chemical compound OC.ClCCl WGLUMOCWFMKWIL-UHFFFAOYSA-N 0.000 description 1
• ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
• 125000001028 difluoromethyl group Chemical group [H]C(F)(F)* 0.000 description 1
• 125000005805 dimethoxy phenyl group Chemical group 0.000 description 1
• 238000006073 displacement reaction Methods 0.000 description 1
• 229960003638 dopamine Drugs 0.000 description 1
• 230000003291 dopaminomimetic effect Effects 0.000 description 1
• 238000007876 drug discovery Methods 0.000 description 1
• 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 1
• 238000005516 engineering process Methods 0.000 description 1
• 239000002024 ethyl acetate extract Substances 0.000 description 1
• DBPFRRFGLYGEJI-UHFFFAOYSA-N ethyl glyoxylate Chemical compound CCOC(=O)C=O DBPFRRFGLYGEJI-UHFFFAOYSA-N 0.000 description 1
• 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
• FFCQTXXGUZQHON-UHFFFAOYSA-N ethyl n-pyrimidin-2-ylcarbamate Chemical compound CCOC(=O)NC1=NC=CC=N1 FFCQTXXGUZQHON-UHFFFAOYSA-N 0.000 description 1
• 238000011156 evaluation Methods 0.000 description 1
• 238000001704 evaporation Methods 0.000 description 1
• 230000008020 evaporation Effects 0.000 description 1
• 238000002073 fluorescence micrograph Methods 0.000 description 1
• 125000004216 fluoromethyl group Chemical group [H]C([H])(F)* 0.000 description 1
• 239000006260 foam Substances 0.000 description 1
• 238000009472 formulation Methods 0.000 description 1
• 125000002541 furyl group Chemical group 0.000 description 1
• 229940097042 glucuronate Drugs 0.000 description 1
• 239000001963 growth medium Substances 0.000 description 1
• 125000001188 haloalkyl group Chemical group 0.000 description 1
• 125000005059 halophenyl group Chemical group 0.000 description 1
• 238000010438 heat treatment Methods 0.000 description 1
• 125000005842 heteroatom Chemical group 0.000 description 1
• 238000011141 high resolution liquid chromatography Methods 0.000 description 1
• 238000004896 high resolution mass spectrometry Methods 0.000 description 1
• 239000003906 humectant Substances 0.000 description 1
• 238000003384 imaging method Methods 0.000 description 1
• 125000002962 imidazol-1-yl group Chemical group [*]N1C([H])=NC([H])=C1[H] 0.000 description 1
• 239000012535 impurity Substances 0.000 description 1
• 208000019014 inability to feed Diseases 0.000 description 1
• QNLOWBMKUIXCOW-UHFFFAOYSA-N indol-2-one Chemical group C1=CC=CC2=NC(=O)C=C21 QNLOWBMKUIXCOW-UHFFFAOYSA-N 0.000 description 1
• PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Chemical group CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
• RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Chemical group C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
• 239000012442 inert solvent Substances 0.000 description 1
• 230000004054 inflammatory process Effects 0.000 description 1
• 230000005764 inhibitory process Effects 0.000 description 1
• 239000007924 injection Substances 0.000 description 1
• 238000002347 injection Methods 0.000 description 1
• 238000002955 isolation Methods 0.000 description 1
• VYCKDIRCVDCQAE-UHFFFAOYSA-N isoquinolin-3-amine Chemical compound C1=CC=C2C=NC(N)=CC2=C1 VYCKDIRCVDCQAE-UHFFFAOYSA-N 0.000 description 1
• CTAPFRYPJLPFDF-UHFFFAOYSA-N isoxazole Chemical group C=1C=NOC=1 CTAPFRYPJLPFDF-UHFFFAOYSA-N 0.000 description 1
• 150000002611 lead compounds Chemical class 0.000 description 1
• 230000002197 limbic effect Effects 0.000 description 1
• 230000000670 limiting effect Effects 0.000 description 1
• 239000006194 liquid suspension Substances 0.000 description 1
• 229910052744 lithium Inorganic materials 0.000 description 1
• 239000012280 lithium aluminium hydride Substances 0.000 description 1
• 239000012139 lysis buffer Substances 0.000 description 1
• 239000011777 magnesium Substances 0.000 description 1
• 229910052749 magnesium Inorganic materials 0.000 description 1
• 229910001629 magnesium chloride Inorganic materials 0.000 description 1
• VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
• 210000004962 mammalian cell Anatomy 0.000 description 1
• 230000007246 mechanism Effects 0.000 description 1
• 229960003194 meglumine Drugs 0.000 description 1
• 238000002844 melting Methods 0.000 description 1
• 230000008018 melting Effects 0.000 description 1
• 230000003340 mental effect Effects 0.000 description 1
• GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 description 1
• QSRRZKPKHJHIRB-UHFFFAOYSA-N methyl 4-[(2,5-dichloro-4-methylthiophen-3-yl)sulfonylamino]-2-hydroxybenzoate Chemical compound C1=C(O)C(C(=O)OC)=CC=C1NS(=O)(=O)C1=C(Cl)SC(Cl)=C1C QSRRZKPKHJHIRB-UHFFFAOYSA-N 0.000 description 1
• QGBPKJFJAVDUNC-UHFFFAOYSA-N methyl 4-methoxy-3-oxobutanoate Chemical compound COCC(=O)CC(=O)OC QGBPKJFJAVDUNC-UHFFFAOYSA-N 0.000 description 1
• XLTANAWLDBYGFU-UHFFFAOYSA-N methyllycaconitine hydrochloride Natural products C1CC(OC)C2(C3C4OC)C5CC(C(C6)OC)C(OC)C5C6(O)C4(O)C2N(CC)CC31COC(=O)C1=CC=CC=C1N1C(=O)CC(C)C1=O XLTANAWLDBYGFU-UHFFFAOYSA-N 0.000 description 1
• 239000007758 minimum essential medium Substances 0.000 description 1
• 230000004048 modification Effects 0.000 description 1
• 238000012986 modification Methods 0.000 description 1
• HDZGCSFEDULWCS-UHFFFAOYSA-N monomethylhydrazine Chemical compound CNN HDZGCSFEDULWCS-UHFFFAOYSA-N 0.000 description 1
• 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
• 235000019796 monopotassium phosphate Nutrition 0.000 description 1
• 210000003205 muscle Anatomy 0.000 description 1
• BRSUAKMKDAAYJX-UHFFFAOYSA-N n-(2-amino-1,3-benzothiazol-6-yl)acetamide Chemical compound CC(=O)NC1=CC=C2N=C(N)SC2=C1 BRSUAKMKDAAYJX-UHFFFAOYSA-N 0.000 description 1
• NYKOHJDWRQIEQZ-UHFFFAOYSA-N n-(3-methyl-1,2,4-oxadiazol-5-yl)-1,1-bis(methylsulfanyl)methanimine Chemical compound CSC(SC)=NC1=NC(C)=NO1 NYKOHJDWRQIEQZ-UHFFFAOYSA-N 0.000 description 1
• FMASTMURQSHELY-UHFFFAOYSA-N n-(4-fluoro-2-methylphenyl)-3-methyl-n-[(2-methyl-1h-indol-4-yl)methyl]pyridine-4-carboxamide Chemical compound C1=CC=C2NC(C)=CC2=C1CN(C=1C(=CC(F)=CC=1)C)C(=O)C1=CC=NC=C1C FMASTMURQSHELY-UHFFFAOYSA-N 0.000 description 1
• FUCCVTKQLLOEPO-UHFFFAOYSA-N n-(5-methoxy-[1,3]thiazolo[5,4-b]pyridin-2-yl)imidazole-1-carbothioamide Chemical compound S1C2=NC(OC)=CC=C2N=C1NC(=S)N1C=CN=C1 FUCCVTKQLLOEPO-UHFFFAOYSA-N 0.000 description 1
• WDINSPOQKMZCHQ-UHFFFAOYSA-N n-(5-phenyl-1,3-thiazol-2-yl)imidazole-1-carbothioamide Chemical compound C1=CN=CN1C(=S)NC(S1)=NC=C1C1=CC=CC=C1 WDINSPOQKMZCHQ-UHFFFAOYSA-N 0.000 description 1
• YPWKLBCTOUEZKE-UHFFFAOYSA-N n-(6-chloropyridin-2-yl)-2,2-dimethylpropanamide Chemical compound CC(C)(C)C(=O)NC1=CC=CC(Cl)=N1 YPWKLBCTOUEZKE-UHFFFAOYSA-N 0.000 description 1
• DUZMBBAWLGCEQE-UHFFFAOYSA-N n-(6-chloropyrimidin-4-yl)-1,1-bis(methylsulfanyl)methanimine Chemical compound CSC(SC)=NC1=CC(Cl)=NC=N1 DUZMBBAWLGCEQE-UHFFFAOYSA-N 0.000 description 1
• YJZQFLXZZGZDKK-UHFFFAOYSA-N n-[(2,4-dimethoxyphenyl)methyl]-6-methoxyquinoxalin-2-amine Chemical compound COC1=CC(OC)=CC=C1CNC1=CN=C(C=C(OC)C=C2)C2=N1 YJZQFLXZZGZDKK-UHFFFAOYSA-N 0.000 description 1
• NTKLQWVHHBNEPH-UHFFFAOYSA-N n-[(2,4-dimethoxyphenyl)methyl]-7-methoxyquinoxalin-2-amine Chemical compound COC1=CC(OC)=CC=C1CNC1=CN=C(C=CC(OC)=C2)C2=N1 NTKLQWVHHBNEPH-UHFFFAOYSA-N 0.000 description 1
• FBMCKFANBCCIFK-UHFFFAOYSA-N n-[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]imidazole-1-carbothioamide Chemical compound C1=CC(OC)=CC=C1C1=CSC(NC(=S)N2C=NC=C2)=N1 FBMCKFANBCCIFK-UHFFFAOYSA-N 0.000 description 1
• OESGJWFGVHFAAE-UHFFFAOYSA-N n-[4-(4-methoxyphenyl)-5-methyl-1,3-thiazol-2-yl]imidazole-1-carboxamide Chemical compound C1=CC(OC)=CC=C1C1=C(C)SC(NC(=O)N2C=NC=C2)=N1 OESGJWFGVHFAAE-UHFFFAOYSA-N 0.000 description 1
• NNKPHNTWNILINE-UHFFFAOYSA-N n-cyclopropyl-3-fluoro-4-methyl-5-[3-[[1-[2-[2-(methylamino)ethoxy]phenyl]cyclopropyl]amino]-2-oxopyrazin-1-yl]benzamide Chemical compound CNCCOC1=CC=CC=C1C1(NC=2C(N(C=3C(=C(F)C=C(C=3)C(=O)NC3CC3)C)C=CN=2)=O)CC1 NNKPHNTWNILINE-UHFFFAOYSA-N 0.000 description 1
• 229930014626 natural product Natural products 0.000 description 1
• 210000002569 neuron Anatomy 0.000 description 1
• 230000007996 neuronal plasticity Effects 0.000 description 1
• 229920002113 octoxynol Polymers 0.000 description 1
• 229910052763 palladium Inorganic materials 0.000 description 1
• 230000007170 pathology Effects 0.000 description 1
• 230000007310 pathophysiology Effects 0.000 description 1
• 239000008188 pellet Substances 0.000 description 1
• 235000019371 penicillin G benzathine Nutrition 0.000 description 1
• 210000001428 peripheral nervous system Anatomy 0.000 description 1
• NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
• 239000010452 phosphate Substances 0.000 description 1
• 230000001766 physiological effect Effects 0.000 description 1
• LZMJNVRJMFMYQS-UHFFFAOYSA-N poseltinib Chemical compound C1CN(C)CCN1C(C=C1)=CC=C1NC1=NC(OC=2C=C(NC(=O)C=C)C=CC=2)=C(OC=C2)C2=N1 LZMJNVRJMFMYQS-UHFFFAOYSA-N 0.000 description 1
• 230000008092 positive effect Effects 0.000 description 1
• 239000011591 potassium Substances 0.000 description 1
• 229910052700 potassium Inorganic materials 0.000 description 1
• 229910000027 potassium carbonate Inorganic materials 0.000 description 1
• NNFCIKHAZHQZJG-UHFFFAOYSA-N potassium cyanide Chemical compound [K+].N#[C-] NNFCIKHAZHQZJG-UHFFFAOYSA-N 0.000 description 1
• GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
• 230000036515 potency Effects 0.000 description 1
• 238000002360 preparation method Methods 0.000 description 1
• DBABZHXKTCFAPX-UHFFFAOYSA-N probenecid Chemical compound CCCN(CCC)S(=O)(=O)C1=CC=C(C(O)=O)C=C1 DBABZHXKTCFAPX-UHFFFAOYSA-N 0.000 description 1
• 229960003081 probenecid Drugs 0.000 description 1
• 238000012545 processing Methods 0.000 description 1
• 108090000623 proteins and genes Proteins 0.000 description 1
• 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
• 239000012264 purified product Substances 0.000 description 1
• XFTQRUTUGRCSGO-UHFFFAOYSA-N pyrazin-2-amine Chemical compound NC1=CN=CC=N1 XFTQRUTUGRCSGO-UHFFFAOYSA-N 0.000 description 1
• PBMFSQRYOILNGV-UHFFFAOYSA-N pyridazine Chemical group C1=CC=NN=C1 PBMFSQRYOILNGV-UHFFFAOYSA-N 0.000 description 1
• NWELCUKYUCBVKK-UHFFFAOYSA-N pyridin-2-ylhydrazine Chemical compound NNC1=CC=CC=N1 NWELCUKYUCBVKK-UHFFFAOYSA-N 0.000 description 1
• QLULGIRFKAWHOJ-UHFFFAOYSA-N pyridin-4-ylboronic acid Chemical compound OB(O)C1=CC=NC=C1 QLULGIRFKAWHOJ-UHFFFAOYSA-N 0.000 description 1
• UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Chemical group COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
• 125000000246 pyrimidin-2-yl group Chemical group [H]C1=NC(*)=NC([H])=C1[H] 0.000 description 1
• OYRRZWATULMEPF-UHFFFAOYSA-N pyrimidin-4-amine Chemical compound NC1=CC=NC=N1 OYRRZWATULMEPF-UHFFFAOYSA-N 0.000 description 1
• SBYHFKPVCBCYGV-UHFFFAOYSA-N quinuclidine Chemical compound C1CC2CCN1CC2 SBYHFKPVCBCYGV-UHFFFAOYSA-N 0.000 description 1
• STECJAGHUSJQJN-FWXGHANASA-N scopolamine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-FWXGHANASA-N 0.000 description 1
• 229960002646 scopolamine Drugs 0.000 description 1
• 239000013049 sediment Substances 0.000 description 1
• 238000007391 self-medication Methods 0.000 description 1
• 230000001953 sensory effect Effects 0.000 description 1
• 238000000926 separation method Methods 0.000 description 1
• 230000000391 smoking effect Effects 0.000 description 1
• MRTAVLDNYYEJHK-UHFFFAOYSA-M sodium;2-chloro-2,2-difluoroacetate Chemical compound [Na+].[O-]C(=O)C(F)(F)Cl MRTAVLDNYYEJHK-UHFFFAOYSA-M 0.000 description 1
• 239000011343 solid material Substances 0.000 description 1
• 239000008247 solid mixture Substances 0.000 description 1
• 241000894007 species Species 0.000 description 1
• TZJMKJNKCMKRIJ-UHFFFAOYSA-N spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane] Chemical compound O1CNCC11C(CC2)CCN2C1 TZJMKJNKCMKRIJ-UHFFFAOYSA-N 0.000 description 1
• 230000002739 subcortical effect Effects 0.000 description 1
• KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
• 210000000225 synapse Anatomy 0.000 description 1
• 230000015883 synaptic transmission, dopaminergic Effects 0.000 description 1
• 235000020357 syrup Nutrition 0.000 description 1
• 239000006188 syrup Substances 0.000 description 1
• 229940095064 tartrate Drugs 0.000 description 1
• CZDYPVPMEAXLPK-UHFFFAOYSA-N tetramethylsilane Chemical compound C[Si](C)(C)C CZDYPVPMEAXLPK-UHFFFAOYSA-N 0.000 description 1
• WROMPOXWARCANT-UHFFFAOYSA-N tfa trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC(=O)C(F)(F)F WROMPOXWARCANT-UHFFFAOYSA-N 0.000 description 1
• VLLMWSRANPNYQX-UHFFFAOYSA-N thiadiazole Chemical group C1=CSN=N1.C1=CSN=N1 VLLMWSRANPNYQX-UHFFFAOYSA-N 0.000 description 1
• 125000000437 thiazol-2-yl group Chemical group [H]C1=C([H])N=C(*)S1 0.000 description 1
• ZWZVWGITAAIFPS-UHFFFAOYSA-N thiophosgene Chemical compound ClC(Cl)=S ZWZVWGITAAIFPS-UHFFFAOYSA-N 0.000 description 1
• JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
• 230000001988 toxicity Effects 0.000 description 1
• 231100000419 toxicity Toxicity 0.000 description 1
• 230000009466 transformation Effects 0.000 description 1
• 238000000844 transformation Methods 0.000 description 1
• AVCVDUDESCZFHJ-UHFFFAOYSA-N triphenylphosphane;hydrochloride Chemical compound [Cl-].C1=CC=CC=C1[PH+](C=1C=CC=CC=1)C1=CC=CC=C1 AVCVDUDESCZFHJ-UHFFFAOYSA-N 0.000 description 1
• JUDXOKKZTISQDJ-UHFFFAOYSA-N triphenylphosphane;hydrochloride Chemical compound Cl.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 JUDXOKKZTISQDJ-UHFFFAOYSA-N 0.000 description 1
• 229960000281 trometamol Drugs 0.000 description 1
• 238000003828 vacuum filtration Methods 0.000 description 1
• 210000001186 vagus nerve Anatomy 0.000 description 1
• 239000011534 wash buffer Substances 0.000 description 1
• 239000011701 zinc Substances 0.000 description 1
• 229910052725 zinc Inorganic materials 0.000 description 1
• LYTCVQQGCSNFJU-LKGYBJPKSA-N α-bungarotoxin Chemical compound C(/[C@H]1O[C@H]2C[C@H]3O[C@@H](CC(=C)C=O)C[C@H](O)[C@]3(C)O[C@@H]2C[C@@H]1O[C@@H]1C2)=C/C[C@]1(C)O[C@H]1[C@@]2(C)O[C@]2(C)CC[C@@H]3O[C@@H]4C[C@]5(C)O[C@@H]6C(C)=CC(=O)O[C@H]6C[C@H]5O[C@H]4C[C@@H](C)[C@H]3O[C@H]2C1 LYTCVQQGCSNFJU-LKGYBJPKSA-N 0.000 description 1